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Abstract 
Novel linker N-( { [4-(3-aminopropylcarbamoyl)phenyl]ethylsulphanyl ) methyl)-
2-phenylacetamide 87 has been developed which is compatible with a range of 
reactions (e.g. base, oxidation, alkylation), can be cleaved under mild conditions and 
has the ability to release alcohols and amines. An efficient synthesis of the linker has 
been devised and attachment to a variety of solid supports (Tentagel®, polystyrene) 







As a general building block 2-acetamido-3, 4-di-O-acetyl-2-deoxy-N-(fluoren-
9-yl-methoxycarbonyl)-3D-glucopyranosylan1ine 106 was synthesised in gram 
quantities from N-acetylglucosamine in 8 steps. The saccharide was linked through 
the 6-hydroxyl group onto carboxy-Tentagel® via linker 87 in excellent yield and 
extension of the glycosidic amino group provides a route towards the synthesis of 
glycopeptides. 
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0 CO2Bn 
Peptide = -L-Phe-L-Ala-L-Thr-L-Ile-L-Vat-NHFmoc 
As an alternative, sugar building block 2-acetamido-2-deoxy-N-
(benzyloxycarbonyl)-3-D-glucopyranosylamjne 129 was synthesised from N-
acetyiglucosamine in 5 steps. The saccharide was attached onto carboxy Tentagel® 
via linker 87 and has been used in initial studies into esterification reactions to 
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129 	 R1 = H; R2 =H or COR; R3 =H or COR 
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BOP Benzotriazolyloxy-tris (dimethyl amino)- 
phosphonium hexafluorophosphate 





C Aromatic carbon 
Cbz Benzyloxycarbonyl 
2-ClTrt 2-Chiorotrityl 
CMP Cytidine monophosphate 
Coil Collidine 
Cp Cyclopentyl 





DCC N, N'-Dicyclohexylcarbodiimide 
DCM Dichioromethane 
DDQ 3-Dichloro-5, 6-dicyano-1, 4-benzoquinone 
Dhbt 4-Dihydro-4-oxo-1, 2, 3-benzotriazole 
DIC N, N'-Diisopropylcarbodiimide 
DIEA N, N'-Diisopropylethylamine 
DMAP 4-Dimethylaminopyridine 
DM17 N, N'-Dimethylformamide 
DMSO Dimethylsulfoxide 
DTBP 2, 6-Di-tert-butylpyridine 
DVB Divinylbenzene 
EDCI 1 -(3-Dimethylaminopropyl)-3-ethylcarbodiimide 
hydrochloride 
EDT Ethanedithiol 
EEDQ 2-Ethoxy- 1 -ethoxycarbonyl- 1, 2-dihydroquinoline 













Glu Glutamic acid 
Gly Glycine 
h Hour 
H Aromatic proton 
HATU 2-( 1 H-9-Azabenzotriazolyloxy)- 1,1,3 ,3-tetramethyluronium 
hexafluorophosphate 
HBTU 2-( 1 H-9-Benzotriazolyloxy)- 1, 1, 3, 3-tetramethyluronium 
hexafluorophosphate 




HPLC High performance liquid chromatography 
Hyl Hydroxylysine 
Hyp Hydroxyproline 
IIDQ 2-Isobutoxy- 1 -isobutoxycarbonyl- 1, 2-dihydroquinoline 
ile Isoleucine 
IR Infrared 
J Coupling constant 
LC-MS Liquid chromatography mass spectrometry 





M Moles per Litre 
Molecular ion 





MHC Major Histocompatibility complex 
MHz MegaHertz 
mp Melting point 
ms Molecular sieves 
MS Mass spectrometry 
Mtr 4-Methoxy-2, 3, 6-trimethylbenzenesulfonyl 
mlz Mass-to-charge 














ppm Parts per million 
PMB p-Methoxybenzyl 





RP Reverse phase 




SPS Solid-phase synthesis 
Su Succinimide 
Sug Sugar 
TBAF Tetrabutylammonium fluoride 
TBAHS Tetrabutylammonium hydrogen sulphate 
TBDMS Tert-Butyldimethylsilyl 
TBDPS Tert-Butyldiphenylsilyl 
TBTU 2-( 1 H-9-benzotriazolyloxy)- 1, 1, 3, 3-tetramethyluronium 
tetrafluoroborate 
TFA Trifluoroacetic acid 






TLC Thin layer chromatography 
TOF Time-of-flight 
Trt Trityl 
TsOH p-Toluenesulfonic acid (Tosic acid) 
Tyr Tyrosine 
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Chapter One; Introduction 
Preface 
Carbohydrates are widely found in nature and perform a variety of important 
functions [1]. For example, oligosaccharides on the surface of cells mediate many 
fundamental cellular processes including embryogenesis, tissue differentiation, 
inflammation and metastasis. Cell surface carbohydrates also function as receptors 
for bacteria, viruses and toxins [2]. Prokaryotic cells produce a variety of 0-linked 
glycoconjugates with potent antitumour or antibiotic activity [3]. Some examples of 
natural carbohydrates are shown in Figure 1. A detailed understanding of the 
interactions between carbohydrates and their various receptors could lead to the 
ability to influence important recognition events and develop novel therapeutics. 
(a) 	p1,4 	
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Figure 1: Examples of carbohydrates. (a) Structure of Le, a natural cell surface oligosaccharide 
involved in both normal and pathogenic cell recognition processes. The shape of the molecule is 
largely determined by the glycosidic linkage conformation, anomeric stereochemistry and point of 
attachment. (b) Structure of vancomycin, a glycopeptide antibiotic. The attached oligosaccharide, 
which contains both a- and /3-linkages, is critical for biological activity. 
1 
One major difficulty in determining an overall understanding of carbohydrates 
is that carbohydrate derivatives are extremely complex to synthesise. This is a result 
of a great number of possibilities for the regioselective combination of monomeric 
sugar units as well as the possible formation of two anomeric linkages, the a or 
linkage. Biochemical studies on carbohydrate recognition also require access to both 
the natural carbohydrate and a set of related analogues that can be used to probe the 
role of particular structural features in binding. 	Unfortunately, conventional 
strategies for carbohydrate synthesis are so time consuming that progress in studies 
on carbohydrate recognition has been painstakingly slow. A solid-phase approach 
could dramatically accelerate the synthesis of these important compounds. 
2 
1.1. Solid Phase Synthesis 
1. 1.1 General Methodology 
The techniques for solid-phase synthesis (SPS) are based on the pioneering 
work of Merrifield [4], who was the first to utilise substituted resins as the solid-
phase for the synthesis of peptides. Solid-phase naturally lends itself to the 
production of peptides because of the limited range of synthetic transformations that 
are required for synthesis. Each of the key reactions required for peptide synthesis 
has been optimised to allow the production of peptides of sizeable length. 
To be successful, solid-phase organic synthesis relies on three interconnected 
requirements. Firstly, the polymeric support used has to be inert to the conditions of 
synthesis. Secondly, there has to be some means of linking the substrate to this 
support that permits selective cleavage of product from the support without affecting 
the product structure in any way and this linkage unit is invariably called the linker. 
Lastly, a chemical protection strategy must be used to allow selective orthogonal 
protection and deprotection of reactive groups of monomers so that reactions can be 
performed on the solid phase. This is summarised in Scheme 1. 






bead 	 FG(P) = Functional Group (Protected) 	Deprotect 
FG1(P) 
Linker 	A FG2 
FG1(P) 	FG3(P) 	
Couple 
Linker A FG2--[]k~FG4(P) 




:J~ FG2 	FG 	 FG6(P) 
Compound synthesised on solid support 
Scheme 1: A schematic overview of solid-phase synthesis as used in peptide and oligonucleotide 
synthesis. 
3 
Solid-phase routes often allow the use of excess reagents to force reactions to 
completion. Other benefits often quoted when compared to solution phase methods 
are the ease of isolation at each step by simple filtration, the ease of automation and 
also the pseudo dilution effect [5], which can be synthetically useful in crosslinking 
or cyclisation reactions. 
The main disadvantages of solid-phase chemistry are the extra labour required 
to develop a solid-phase route, the limitations of the current range of commercially 
available supports and linkers as well as limited means of monitoring reactions in 
real time. Solid-phase routes also necessitate additional steps to link and cleave to 
and from the support and are generally used to prepare less than 100 milligram of 
final product. 
1.1.2 Solid Supports 
The earliest forms of resin used were partially crosslinked polystyrene beads 
(styrene is copolymerised with 1 % divinylbenzene to give strength and insolubility 
whilst still permitting flexibility apparent during swelling) in a wide variety of sizes, 
prepared by light- or radical-catalysed polymerisation in an aqueous/organic mixture. 
Polymerisation takes place in micro droplets giving beads of approximately spherical 
shape. Sieving ensures the consistency of size. 
The earliest form of polystyrene resin (Merrifield resin, 1) used for peptide 
synthesis was derivatised with a chioromethyl group to which amino acids could be 
coupled by nucleophilic displacement (Scheme 2). The resulting ester bond 2 was 
stable to the conditions of peptide synthesis and was cleaved to give carboxylic acid 





Scheme 2: Merrifield chioromethyl resin used for the attachment of carboxylic acids. 
in 
Many alternative linking chains on polystyrene have been designed and 
described which are more labile to acid cleavage and these resins were used 
extensively for many years. As more and more groups have used them, it has 
become apparent that the resin has a significant effect on the rate and extent of 
reactions. The hydrophobic nature of the polystyrene and the hydrophilic nature of 
the growing peptide chain causes the latter to fold up. Rather than being solvated, 
internal hydrogen bonding of the peptide limits access to the exposed growing end 
chain, which results in variable reaction yields. Alternative resins have been 
investigated to alleviate these problems. The polyamide resin [6] developed by 
Sheppard et al is more hydrophilic like the growing peptide and the resin can be 
readily solvated by aprotic solvents such as DMF. For molecules other than 
peptides, there has been much use of the Tentagel® resin [7] (Rapp Polymere 
GmbH), which consists of about 80 % polyethylene glycol, grafted to cross-linked 
polystyrene. This resin is considered much more closely related to ether and 
tetrahydrofuran and consequently it has the potential for compatibility with a large 
range of reactions that are currently being investigated. 
Other materials have been used for SPS including cellulose in the form of 
'Perloza' beads [8], paper [9] and cotton [10]. Controlled pore glass (CPG) has also 
been reported to be a good alternative support [11] because no preswelling is 
required and has proven to be successful in solid-phase synthesis of oligonucleotides 
and light-induced spatially addressable parallel synthesis. 
1.1.3 The Linker 
SPS requires a covalent linker group to attach the small molecule onto the 
polymeric resin. This linker bears many similarities to protecting groups in solution 
phase synthesis in as much as it needs to be stable to the reaction conditions used 
during the elaboration of the small molecule. It needs to be cleaved selectively at the 
end of the synthesis thus releasing the small molecule from the resin into solution. It 
should be noted that compared to solution phase synthesis this requirement for a 
linker often adds two additional synthetic steps to a solid-phase route. Properties of a 
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Historically, classical solid-phase peptide synthesis [4] has made use of an ester 
group (mentioned earlier) as a linker stable to peptide coupling conditions but 
cleaved by acid (I-IF) promoted hydrolysis thus liberating a carboxylic acid (Scheme 
3). Other acid labile linkers have been developed for peptide synthesis and these can 
be cleaved using less harsh conditions and can liberate groups other than carboxylic 
acids (Scheme 3). 
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Scheme 3: Acid cleavable linkers. 
The growing desire to synthesise increasingly diverse, non-peptide small 
molecules has led to a requirement for linkers which do not necessarily lead to a 
polar carboxylic acid group upon cleavage and currently a wide variety of these 
linkers exist [12]. The selection of the most appropriate linker for a particular class 
of target molecule is a key factor in designing a solid phase synthesis. 
1.1.4 Reaction Monitoring [13] 
Once the solid support and synthetic route has been selected, the next problem 
concerns the monitoring of reactions. In solution this would normally be performed 
using some form of chromatography (i.e. TLC). However, once the molecule is 
bound to an insoluble support, chromatographic monitoring can only be made 
possible after cleavage and work up procedures. For many supports this is very 
labour intensive and is normally only an option for linker functionalised supports 
which allow clean and fast release of substrate into a suitable solvent for trace 
analysis. 
Useful techniques for on-resin monitoring are non-destructive techniques such 
as IR [14] and gel-phase NMR [15] which give useful results with standard 
laboratory instrumentation. However, the success of such techniques relies heavily 
on the loading of the substrate. Fully solvated resins give good quality 13C NMR 
spectra under standard acquisition conditions and both PS-DVB and PEG-PS-DVB 
resins give similar quality spectra. More specialised equipment such as a high-
resolution magic angle spinning probe is necessary to obtain good quality proton 
spectra and 'H-'3C correlation spectra from polymer supported molecules [16], 
although the results can sometimes justify the expense. 
Mass analysis using MALDI-TOF MS has been demonstrated as a useful 
analytical method for bead analysis [17]. There are also a range of classical 
analytical techniques which can give useful information on the progress of solid-
phase reactions, such as titration of functional groups (amine, acids, thiols, etc); 
elemental analysis; gravimetric analysis; colour tests [18] (Ellman-thiols, Kaiser-
amines, bromophenol blue-basic nitrogen, chioroanil- secondary vs. tertiary amine). 
7 
1.1.5 Experimental Conditions (vessels and agitation) 
Typical glassware used for solution phase synthesis can also be suited to solid-
phase reactions. Disposable fritted polypropylene vessels (isolute tubes) [19] are 
useful for carrying out solid-phase reactions at ambient temperature, although some 
solvents/reagents will leach plasticiser from the reaction vessel on cleavage of the 
product from the solid support. 
Solid supports show varying levels of fragmentation during agitation and this 
breakdown is more pronounced at elevated temperatures. Hence, great care must be 
taken when deciding on methods of agitation [20]. Resins can successfully be stirred 
magnetically, but intermittent stirring and very low stirrer speeds must be used to 
avoid breakdown of beads and subsequent loss of material. Mechanical stifling (low 
speeds), gas sparging, vortexing and shaking are all less destructive methods of 
agitation than magnetic stirring, and sonification for short periods can also be used 
without detrimental effects with many supports. It is also generally accepted that 
allowing reactions to stand without agitation gives good results when using swelling 
solvents and high yielding reaction. 
1.2. Polymer-Supported Syntheses of Glycopeptides 
1.2.1 Overview 
Linkages between carbohydrates and polypeptide chains can be divided into 
two principal groups: (1) those bearing an N-glycosidic linkage to L-asparagine and 
(2) those bearing an 0-glycosidic linkage to L-serine, L-threonine, 4-hydroxy-L-
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Figure 2: Glycopeptide linkages. 
Both N-linked and 0-linked glycopeptides and various structural analogues 
thereof are important for pharmaceutical, immunological, medical and biological 
research [21]. Various functional roles for carbohydrate moieties in glycoproteins 
have been postulated [1], including molecular recognition processes, control of 
membrane permeability and trafficking, protection from proteolytic attack, 
immunological masking, as well as the initiation and control of protein folding [22]. 
However, much information, pivotal to understanding the precise functions of these 
oligosaccharide moieties in living systems, is still not available. 
Despite the tremendous amount of research that has been committed to unveil 
the biosynthetic pathways and biological effects of protein glycosylation, even for 
the more extensively studied classes of glycoproteins, the biological roles of the 
saccharide moiety of these compounds is not well understood [23]. As stated by J.C. 
Paulson [23(a)]: "Multidisciplinary approaches involving biologists, chemists, 
molecular biologists and geneticists will ultimately be required to unravel the 
emerging roles of carbohydrate-recognition signals in complex biological systems 
governing 'social' interactions of cells." This implies that for a more thorough 
understanding of the role of the carbohydrate portions featured in glycoproteins, 
elaborate synthesis and structural analysis of simpler glycopeptides are required [24]. 
This could be undertaken by the use of solid-phase techniques. 
1.2.2 Solid-Phase Synthesis of 0-Linked Glycopeptides 
Recent developments have almost transformed the preparation of small 
glycopeptides carrying simple saccharides into matter of routine and have even put 
glycoproteins within reach of the synthetic chemist. At present, glycosylation of 
protected oligopeptides by chemical means does not constitute a feasible route to 0-
linked glycopeptides, despite attempts by Hollósi et a! [25] involving the coupling of 
an oxazoline sugar derivative to resin bound protected peptides which had a serine 
residue present with a free hydroxyl group. However, yields for 0-glycosylation 
were low. Instead, the most general synthetic route employs glycosylated amino 
acids for stepwise assembly of 0-glycopeptides, preferably on solid-phase. 
Synthetic routes to suitably protected glycosylated amino acids therefore constitute a 
key success in the synthesis of glycopeptides. 
The first method for the solid-phase synthesis of 0-linked glycopeptides 
reported by Guilleman et al [26] involved attachment of Merrifield resin to alanine, 
which was subsequently coupled with an N-Boc-0-glycosyl serine derivative 3. 
Subsequent removal of the N-Boc group on serine with TFA allowed formation of a 
new amine ready for subsequent iterative coupling to the required amino acids using 
















(i)DCC, HOBt, DCM:DMF (3: 1), RT, 2h; (ii) TFA:DCM; Boc-Gly-OH, DCC, DCM, RT, 2h; 
(iv) Anisole, HF, -20 °C for 0.5h then 0 °C for 0.3h. 
Scheme 4: Guilleman et al general strategy for the synthesis of 0-linked glycopeptides. 
Since O-glycosyl-fl-hydroxyl carboxyl acid derivatives are sensitive to both 
strong acid (bond cleavage and anomerisation) and strong base (/3-elimination and 
racemization) suitable acid- and base-labile protecting groups are required. This 
early approach, reported by Guilleman et al, to solid-phase synthesis of 0-linked 
glycopeptides relies on the tert-butyloxycarbonyl (Boc) group for a-amino group 
protection. 	This process, however, requires repeated Nadeprotection  with 
trifluoroacetic acid and final cleavage from the solid phase with a strong acid, which 
are likely to cleave glycosidic bonds. Protection of the a-amino group with the base 
labile fluoren-9-ylmethoxycarbonyl (Fmoc) group (Scheme 5) has shown to be 
attractive in this respect due to its mild sensitivity to weak organic bases such as 
morpholine [27] and piperidine [28] which was later reported to be the base of 
choice. This group thus allows the use of protective groups for amino acid side 
chains and linkers on the solid phase, which are cleaved by moderately strong acid 
such as trifluoroacetic acid [29]. 
Work reported by Liming et al [30] illustrates the use of the Fmoc group and 
reiterates the general strategy towards 0-glycopeptides. The glycosylated amino 
acid building block was synthesised in an 8-step synthesis using Fmoc-threonine 
phenacyl ester, which after glycosylation was de-esterified with zinc in acetic acid to 
give the free acid 4 (Scheme 5). The oncofetal sequence of fibronectin attached to 
glycosylated-threonine 5 was chosen as the target molecule. Fmoc-O-benzyltyrosine 
functionalised SASRIN resin was first treated with 50 % piperidine in DMF to 
remove the Fmoc group and then Fmoc—glycine, Fmoc-proline and Fmoc-histidine 
11 




were successively coupled either as their symmetrical anhydride or 1-
hydroxybenzotriazole ester. Peracetylated Fmoc-O-(a-D-GalNAcp)-threonine 4 was 
then coupled to give resin bound glycopeptide 6. Fmoc-Valine was coupled last and 
after Frnoc removal, the resin was treated with 1 % TFA in DCM to give the desired 
glycopeptide 5. Paulsen et al have also reported [31] using peracetylated Fmoc-O-






R1 = Fmoc; R2 = Ac; R3 = SASRIN-PS; R4 = Bn 
) 
R1 =R2 =R3 =R4 =H,5 
(i) 50% piperidine in DMF; (ii) Fmoc-Gly-OH, DCC, HOBt, DMF, repeat (i);(iii) Fmoc-Pro anhydride, DMF, repeat (i); 
(iv) Fmoc-His(Bn)-01-1, DCC, HOBt, DMF, repeat (i); (v) 7, DCC, HOBt, DMF, repeat (i); 
(vi)Frnoc-Val anhydride, DMF, repeat (i); (vii) 1% TFA, DCM; (viii) 0.1M NaOMe, MeOH; (ix) 10% Pd/C, H2. 
Scheme 5: Liming et al synthesis of the oncofetal sequence offibronectin 5. 
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It was later reported that for temporary protection of the a-carboxyl group, 
pentafluorophenyl (Pfp) esters 7 (Scheme 6) have several advantages in the building 
block synthesis as they serve the dual purpose of protecting the carboxylic acid 
during glycosylation and at the same time activating the carboxyl group for the 
subsequent amide bond formation [32]. The use of such groups therefore avoids 
elaborate orthogonal protection schemes, however, the recoveries of these glycosidic 
amino acids still require a number of steps. 
Meldal et al reported [33] a new strategy towards the synthesis of 0-
glycopeptides in which sugar building block 7 (Scheme 6) is used in the peptide 
synthesis. The transformation of the azido group into acetamido functionality can 
take place after completion of the peptide chain on solid support and deacetylation of 
all sugar residues was also possible on the polymer-bound peptide. In the last step 
the final glycopeptide was cleaved off the resin. Synthesis of sugar building block 2 









R=HorCH3 AcO 0 
AcwXXX_-fj--_Ij_-_ S XXX = Thr or Ser 





OH 	 (iv)-(vi) 
HO AcMtN 
Ac-Pro-Thr-XXX-Thr-Pro-J1e-Ser-ThrNH 
i) A92CO3, AgCI04; (ii) CHC0SH; (iii) N2R4.H20, MeOH; (iv) Fmoc-AA-OPfp, Dhbt-OH; (v) TFA, H20; (vi) HPLC. 
Scheme 6: Meldal et al synthesis of 0-linked glycopeptide using z as the sugar building block. 
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Meldal et al have further illustrated this strategy in the synthesis of highly 
glycosylated 0-glycopeptides with T'-antigenic structures corresponding to human 
glycophorin AN  [34]. It has also been demonstrated that this methodology can be 
used with disaccharide building blocks [35]. It was later reported by Meldal et al 
[36] that the synthesis of oligosaccharides on glycopeptides bound to a solid support 
could also be achieved successfully. Glycopeptides with linear and branched 
trisaccharide side chains were obtained. 
The groups of Schmidt [37], Nakahara [38] and Kihlberg [28, 39] have all been 
productive in this area demonstrating the syntheses of many 0-glycopeptides using a 
variety of threonine and serine building blocks. Many alternative solid supports and 
linkers have been adopted from procedures developed for the solid-phase syntheses 
of peptides. 
A new HYCRAMTM  linker compatible with the reaction conditions necessary 
for N- and O-deprotection of amino acids was introduced by Kunz et al [40] for 
improved polymer supported syntheses of glycopeptides [41]. Amino acids are 
easily attached to the polymer by reaction of the caesium salt of the N-protected 
amino acid, for example 8, with 2-(4-bromo-2-butenamido)methyl-polystyrene 
(HYCRAMTM) 9 (Scheme 7). 
The glycotripeptide 10 was readily removed from the resin using palladium (0)- 
catalysed allyl ester cleavage [40]. 	Under the essentially neutral conditions 
employed, the other protecting groups, as well as the O-glycosidic bond, remained 
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(i) TFA; (ii) DCC, HOBt; (iii) Morpholine; (iv) Cbz-Ala-01-1, DCC, HOBt; (v) [Ph3P]4Pd, morpholine. 
Scheme 7: Kunz et al syntheses of 0-linked glycopeptides using HYCRAMTM linker 2. 
While glycopeptides could be detached from the resin in high yields when the 
Boc strategy was used, reduced yields were observed using the much-preferred Fmoc 
group. Studies showed that upon exposure to morpholine for 3 days, 12 % of the 
allyl ester was aminolysed. As in many solid-phase syntheses, losses can occur at 
the dipeptide stage (formation of diketopiperazine) and due to steric hindrance, 
during the cleavage step itself. A new anchor of the allyl ester type was therefore 
designed 11 (Scheme 8) [43], which incorporated a flexible, polar spacer in order to 
reduce steric hindrance and associations with the polystyrene matrix [44]. This 
anchor also replaced the o fl-unsaturated carbonyl structure, which in turn increased 
stability against nucleophilic attack. This newly developed linker 11 was used in the 
synthesis of glycononapeptide 12 [45] as outlined in Scheme 8. Peptide j 


















H 	II II 
N)c 
H 
/ 	H 	2 
CH3 
(i) DMF, morpholirie; (ii) Boc-Pro-OH, DIC, HOBt; (iii) DCMITFA [1/1]; (iv) DIEAIDCM [1/10]; 
(v) Fmoc-Ala-OH, DIC, HOBt; (vi)Fmoc-AA-OH, TBTU, DIC, HOBt; (Vii) [(PPh3)4Pd], morpholine, DMF/DMSO [1/1]; 
(viii) TFAJMeSEIIMeOPh [40/1/1]; (ix) NaOMe, MeOH. 
Scheme 8: Kunz et al syntheses of MUC-1 repeating unit glycononapeptide 12 using the 
HYCRONTM anchor 11. 
Recently, Nakahara et at have reported [46] a novel silyl linker 13 for the 
synthesis of glycopeptides, which enables the side-chain hydroxyl groups of the 
peptide or glycopeptide to bind to the solid support. A key feature of this approach is 
the feasibility of peptide chain-elongation at both N- and C-termini. Synthesis of this 
linker can be achieved in 3 steps (Scheme 9). 
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Chloro( z, a-dimethylbenzyl)dimethylsilane jj was first hydrolysed with 
aqueous KOH to give silanol j. Nitration of this compound with ammonium 
nitrate-trifluoroacetic anhydride afforded p-nitro compound 16, after which 
chlorination with oxalyl chloride gave linker 13. fl-Hydroxy amino acids can then be 
attached using 13, Nal and NMM in DMF which gave the most consistent yields 
towards 17. Reduction of the nitro group was achieved using Zn-AcOH to give the 
aniline derivative 18, which was treated with succinic anhydride to afford j. The 
carboxylic acid of 19 was then activated and attached to Gly-preloaded Wang resin 
to give 20, which can then be further derivatised at the N-termini using 21 to give 22 
[47]. Isolation of the synthesised glycopeptide 22 was readily accomplished by 
fluoride ion-mediated hydrolysis and simple chromatographic purification. 
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x_i_f_-_t(j 	 X— i--_f__(__NO, 	 R = H or CH3 
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X=C1,14 . 	 - X = OH, 16 	
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X = OH, 15 - = 	
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(i) KOH; (ii) N114NO3, (CF3CO)2o, CH3CN; (iii) (COd)2, DMF, DCM; (iv) Nal, NMM, DMF; (v) Zn-AcOH; 
(vi) succinic anhydride, DCM; (vii) polymer-Wang-GIy-NH2, HBTU, HOBt, DIEA, NMP; (viii) 50% piperidine in NMP; 
(ix) 21, HBTU, HOBt, NMP; (x) CsF, AcOH, DMF. 
Scheme 9: Nakahara et al syntheses of glycopeptides using silyl linker 13 (N-terminal). 
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H3C—i—CH3  
This methodology was also shown to be useful in C-terminal peptide chain 
elongation as demonstrated with the synthesis of 23 (Scheme 10) [47]. Attachment 
of 24 was achieved using linker 13, O-glycosyl-fi-hydroxyl carboxyl acid derivative 
j and imidazole to give 25, which can be further manipulated to glycopeptide 
oligomer 26 by coupling 27. Removal of the Fmoc group yields 23 which can be 
further manipulated at the N-terminus. 
OBn OBn OH OH 









R = All 25" 
- (v) 
R=H 1 
R=Fmoc,26\ - ' (vii) 
R=H,23 1 
-AIaOBri 
(i) Nal, NMM, DMF; (ii) Zn-AcOF1; (iii) succinic anhydride, DCM; (iv) polymer-HMP-GIy-NH2, HBTU, HOBt, DIEA, NMP; 
(v) [(PPh3)Pd], dimedone, THF; (vi) 27, HBTU, HOBt, DIEA, NMP; (vii) 50% piperidine in NMP. 
Scheme 10: Nakahara et al syntheses of glycopeptides using silyl linker 13 (C-terminal). 
1.2.3 Solid-Phase Synthesis of N-Linked Glycopeptides 
Synthesis of N-glycopeptides have been carried out most often by the stepwise 
approach, in which a fl-glycosyl amine is coupled to a suitably-protected Asp 
derivative to give an Asn(Sug) derivative. /3-Glycosyl amines have generally been 
synthesised by reduction of the corresponding azides [48] and can be illustrated by 
the synthesis of CD52 glycopeptide 28 (Scheme 11) that was reported by Nakahara 
et al [49]. The first step of the synthesis was the preparation of the key building 
block 29. Once the core pentasaccharide azide 30 was achieved in 5 steps, the next 
key reaction was reduction of the azide to the corresponding amine. This was 
achieved successfully using a Lindlar catalyst under a hydrogen atmosphere followed 
by selective acylation of the resulting oligosaccharyl amine by activated aspartic acid 
31 using the standard HOBt/DCC activation method. The final step towards the core 
pentasaccharide-Asn conjugate 29 was deprotection of the carboxylic acid using 
TFA in DCM in an overall yield of 23 %. The synthetic strategy involved the 
automated synthesis of Asp 4-Ser'2  peptide on an F[MP resin using the traditional 
Fmoc method. Manual coupling to the Asn pentasaccharide 29 was achieved using 
HOBt and DCC in 98 % yield. The glycopeptide was then reapplied to the automatic 










































(i) Silver alumina silicate, 4A ms, DCM, 0 °C-RI, 3h; (ii) 4A ms, Cp2HfCl2, AgCI04, 34, DCM, -20 °C-RT, 16h; (iii) 
IJr(COD)(PMePh2)21PF6, THF, RI, lh; HgOf}-lgCl2, (CH3)2CO3 RT, lh; (iv) AgOIf, 4A ms, 35, DCM, -40 °C-RT, 16h; (v) a) 
NH2(CH2)2NH2, n-BuOH, 90 °C, 44h; b) Ac20, MeOFI, 0 °C, 2h; (vi) a) Lindlar cat., H2, MeOH, RI, 16h; b)31, DCC, HOBt, 
DCM, RI, 16h; c) TFA, DCM, RI, 2h; (vii) a) Peptide-FIMP-Resin, HOBt, DCC, RI, lh; b) 20 % piperidine in NMP; c) 
Fmoc-AA-OH, HOBt, DCC, RI, 2h; (Viii) a) 95 % IFA,! 2.5 % EDI/1120, RI, 2h; b) 20 % Pd(OH)21C, H2, EIOH, H20, RI. 
Scheme 11: Nakahara et al synthesis of CD52 glycopeptide 28 using core pentasaccharide-Asn 
conjugate 30. 
In 1997 Toth et al synthesised unnatural N-linked glycopeptides in order to 
synthesise C-terminal carbohydrate enkephalins [50]. In this work a modified 
glucuronic acid was immobilised on a polystyrene based support via a 2-chiorotrityl 
linker 36 (Scheme 12). Reduction of the resin bound sugar-azide was achieved by 
treatment with a mixture of triethylamine and propane-1, 3-dithiol to generate the 
free amine in situ [51] which was coupled to monosaccharide 37 using HBTU and 
20 
HOBt as the coupling reagents to give resin bound dimer 38. 36 and 38 were used in 
peptide synthesis using standard coupling procedures. Upon completion of the 
syntheses, the N-terminal Fmoc group was removed followed by hydrazine-mediated 
deprotection of the sugar acetates. Acidolytic resin cleavage and concomitant side 
chain deprotection relinquished the carbohydrate-modified enkephalins 39, 40 and 
41. The carboxamide analogue 42 of glycoconjugates 39 was also synthesised by 
initial immobilisation of the glycosyl azide onto NovaSyn TGR resin modified with 
the Rink linker. 
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(i) 2-Cit resin, DIEA, DCM; (ii) a) EDT, Et3N; b) HBTU, HOBt, DIEA, DMF; (iii) 20% piperidine in DMF; 
(iv) Fmoc-AA-OH: Leo or Met, Phe, Gly, and Tyr(OBu), HBTU, HOBt, DIEA; 
(v) X = Leo, TFAI}120/TIPS (95/2.5/2.5) or  = Met, TFA/H20IEDT,TJPS (92.5/2.5/2.5/2.5). 
Scheme 12: Toth et al synthesis of C-terminal carbohydrate enkephalins. 
More recently, several groups [52] have begun to use the much simpler 
approach introduced by Kochetkov et al [53], in which the reducing oligosaccharide 
is treated for an extended period of time with saturated aqueous ammonium 





Asn(Sug) derivative synthesised is then deprotected and elongated to give the desired 
glycopeptide. There are several solid-phase methods available which utilise this 
approach [52(a), 54] and this methodology can be illustrated by the work of Meldal 
et al [55] in the synthesis of N-glycopeptide 43 (Scheme 13). Synthesis of the sugar 
building block 44 can be then achieved in 5 steps using 45, which can then used in 
the solid-phase assembly of N-linked glycopeptide 43 employing Dhbt esters 
conducted on a fully automated peptide synthesiser. The glycopeptide was cleaved 
off the resin using TFA and purified using HPLC. 
OH 	(i)-(iv) 	 OAc 	(v) 	 OAc 
HO 9\,OH 	ACoAcO39NH  
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(i) Satd. aq. NH4HCO3 ; (ii) Fmoc-OSu, pyr; (iii) Ac20, pyr; (iv) 20% piperidine in THF; (v) 45, N-Ethyl-morpholine, THF; 
(Vi) TFA, DCM; (Vii) HPLC; (viii) NaOMe, MeOH; (ix) HPLC. 
Scheme 13: Meldal et al syntheses of N-linked glycopeptide 43. 
This methodology was later used in the synthesis of a D-A1a1  peptide-T amide 
analogue [561 utilizing the Rink linker. 
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Meldal et al later reported [57] that the carbohydrate building block can not 
only be prepared synthetically but can be released in a suitable form from natural 
glycoproteins using routine hydrazinolysis techniques as illustrated in Scheme 14. 
For example, a series of N-linked oligosaccharides have been released intact in their 
unreduced form from fetuin and ribonuclease B using hydrazinolysis. The respective 
glycosylamine 46 was then obtained by the Kochetkov method and coupled to the 
side chain of activated aspartic acid derivative 47 to give 48, thus allowing their 
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(iv) 
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48 NHAc 0 NHFmoc 
(i) NH2NH2, 85°C, 12h; (ii) Ac20, aq. NaHCO3; (iii) Cu(OAc)2, 30mm; (iv) sat. (NH4HCO3; (v) DIEA, DMSO; 
(Vi) Ac20, pyr, 6h; (vii) TFA, Ih. 
Scheme 14: Meldal et al alternative route towards sugar building blocks for N-linked 
glycopeptides. 
An alternative route towards N-linked glycopeptides is illustrated in Scheme 15 
which is methodology reported by Vetter et al [58], although similar procedures were 
reported previously by Lansbury et al [59] and Albericio et al [60]. The peptide 
chain was synthesised on SASRIN resin as normal; however, an allyl-asparagine 
23 
derivative was incorporated into the synthesis instead of a sugar-asparagine 
derivative. After peptide chain elongation was complete the allyl group on 49 was 
removed using Pd (0) to give the carboxylic acid, which was then subsequently 
activated by preparation of the pentafluorophenyl (Pfp) ester derivative. The 
glycosylamine 50 was coupled to the polymer-bound peptide using standard coupling 
reagents (Pfp esters) to give glycopeptide 51. 
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(i) Pd(PPh3)4, NMM, Ac011, CI-1C13; (ii) CF3COOC6F5, DMF; (iii) 50, DIEA, HOBt, DMSO; (iv) 20% piperidine in DMF; 
(v) 50% TFA in DCM. 
Scheme 15: Vetter et al synthesis of N-linked glycopeptides using allyl asparagine derivatives. 
One strategy that involves the construction of the oligosaccharide on a solid 
support was reported by Danishefsky et al and utilises the glycal methodology [61]. 
Both linear and branched oligosaccharides can be constructed in this manner and are 
subsequently modified with anthracenesulfonamide in an azasulfonamidation 
sequence of reactions to afford, for example, polymer bound disaccharide 52 
(Scheme 16). Fucosylation in the 2-position of the galactose moiety gave the 
polymer-bound H-type II blood group determinant trisaccharide derivative 53. 
Acetylation and reduction gave trisaccharidyl amine 54, which was subsequently 
coupled to the protected pentasaccharide using standard coupling procedures. 
24 
Retrieval of the construct and removal from the polymer support provided the 
branched trisaccharide pentapeptide 55 in a 10 % overall yield. An added advantage 
of this route is that since the glycopeptide contains orthogonal protecting groups on 
the C- and N-termini of the peptide, the chain itself can be extended with the 
glycopeptide bound to the polymer. 
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Leu-Ala-Cbz 	 R = silyl linker-PS 
Asn-Leu-Thr(OBut)OAII 	R = H, 	 ) (vii) 
)2Anth 
(i) 1(coll)2004, AnthS02NH2, THF, -10 toO °C; (ii) Bu4NN1, THF; (iii) Sn(OTf)2, DTBP, THF; (iv) Ac20, DMAP, THF; 
(v) I, 3-propanedithiol, DIEA, DMF; (vi) peptide, IIDQ, DCM; (vii) HF.Pyr, anisole, DCM, -10 °C. 
Scheme 16: Dan ishefsky et al synthesis of N-linked glycopeptides using glycal methodology. 
1.2.4 Solid-Phase Chemical-Enzymatic Synthesis of Glycopeptides 
Wong et al reported a new strategy towards branched glycopeptides [62], 
which enables a rapid iterative formation of peptide bonds chemically and glycosidic 
bonds enzymatically with glycosyl transferases on a silica-based solid support 
compatible with both organic and aqueous solvents. The major advantage offered by 
the use of enzymes is that they initiate highly regio- and stereoselective reactions 
without employing protecting groups. This results in reducing the number of 
synthetic steps required to synthesise oligosaccharide derivatives. In the first step, a 
hexaglycine spacer was attached to aminopropyl silica 56 to give 57 (Scheme 17). 
Excess amino groups were capped using acetic anhydride. In the second step, a 
selective cleavage site was implemented for the release of intermediates and final 
products from the support under mild conditions by introduction of a a-
chymotrypsin-sensitive phenylalanyl ester bond [63] 58. Addition of a glycopeptide 
gave acceptor 59 which can then be further manipulated in enzymatic synthesis 
reactions using several glycosyl transferases to give 60. a-Chymotrypsin-catalysed 
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R=H,61 
(i) a) Boc-GIy-OH, DCC, HOBt, DIEA; b) Ac20, pyr; c) 25% TFA, DCM; d) Boc-G1y3-OH, DCC, HOBt; (ii) a) 25% TFA, 
DCM; b) O-(N-Boc-Phenylalanyl)glycolic acid, BOP, HOBt, DIEA; (iii) a) 25% TFA, DCM; b) Boc-Gly-OH, BOP, HOBt, 
DIEA; c)25% TFA, DCM; d) Boc-Asn(G1cNAc/-OH, BOP, HOBt, DIEA; (iv)fli,4-GaJ T, UDP-Gal, HEPES, MnCl2; 
(v) a-2,3-SialyJ 1, CMP-NeuAc, HEPES, MnCl2; (vi) cc-chymotiypsiri, H20. 
Scheme 17: Wong et al chemoenzymatic synthesis of glycopeptides. 
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Wong et al later reported [64] similar work in the chemoenzymatic synthesis of 
the 227-234 sequence of the Mucin domain of MAdCAM- 1 carrying an 0-linked 
SLe'-ligand 62 (Scheme 18). The Fmoc-Ala-HYCRON conjugate 63 was employed 
as the linker and attached to aminopropyl-CPG 64. Removal of the Fmoc groups 
was achieved using morpholine and amino acids were subsequently attached using 
HBTU and NMM as the coupling reagents and the carbohydrate was incorporated as 
the 0-unprotected amino acid glycoside Fmoc-Thr(fl--GIcNAc)-OH 65. Enzymatic 
synthesis was then performed on 66 to give the desired glycopeptide on solid 
support. Cleavage from the solid support was achieved using Pd (0) and morpholine 
to give an overall yield of 9 % (based on the initial amino acid loading of the resin), 
which was achieved after workup of the supernatant. Although it was reported that 
the solution-phase synthesis of 62 gives higher yields, the complete on-resin 
assembly is performed in less than 9 days and offers new opportunities for 
automation and diversification in glycopeptide synthesis. 
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Ac-Lys- Pro- Pro-Asn-Thr-Thr-SerApacj—R 
d
NHAC 
R = HYCRON-CPG 
OH O  H 	 R=H,62 
(i) HBTU, NMM, HOBt, DMF; (ii) a) morpholine, DMF; b) Fmoc-AA-01-1, HBTU, NMM, HOBt, DMF; c) a) and b) repeated, 
N-acylation: AcOH, HBTU, NMM, HOBt, DMF; (iii) TFAIEDT/H20 [40/1/1]; (iv) UDP-Gal, Gal 1; 
(v) CMP-NeuNAc, Sialyl 1; (vi) Pd(PPh3)4, morpholine, DMF, DMSO. 
Scheme 18: Wong et at chemoenzymatic synthesis of the 227-234 sequence of the Mucin domain of 
MAdCAM-1 carrying an 0-linked SLexligand 62. 
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Meldal et al have also reported similar work, which involved the use of a new 
resin consisting of a beaded polyethylene glycol polyacrylamide copolymer 
(PEGA1900) [ 65]. The resin was reported to be mechanically stable, yet highly 
swelling in both organic solvents and aqueous buffers. Scheme 19 illustrates the 




























(i) UDP-GaI, fl(1, 4)GaJT; (ii) TFA, 23 °C, 2h. 
Scheme 19: Meldal et al chemical-enzymatic synthesis of glycopeptide 67. 
1.3. Carbohydrates as Scaffolds 
1.3.1 Overview 
Modern organic/medicinal chemistry is currently undergoing a cultural 
revolution in the way new drugs are discovered. Instead of the time consuming, 
traditional synthesis and screening of one compound at a time, combinatorial 
chemistry can rapidly provide large collections of compounds (i.e. libraries) in a 
short time. These libraries can then be evaluated using high-throughput screening. 
In contrast to the rapid development of combinatorial synthesis in the area of 
small-molecule libraries and biopolymers such as polypeptides, the development of 
combinatorial carbohydrate libraries has been slow in part because of the inherent 
difficulties presented by the polyfunctionality of the compounds. Nevertheless, 
because of their biological significance, strategies to overcome these complications 
have been devised and several reports on carbohydrate libraries have begun to appear 
during the last five years. 
Recently, the field of combinatorial carbohydrate chemistry has been further 
extended by the recognition that carbohydrates can act as highly functionalised 
scaffolds or platforms for projecting pharmacophore groups. Nicolaou et al [66] first 
demonstrated that carbohydrates have the potential as highly functionalised and rigid 
scaffolds. Non-peptide peptidomimetics of the peptide hormone somatostatin (SRIF) 
68 were designed and synthesised utilising fl-D-glucose as novel scaffolding L9. As 
illustrated in Figure 3, such compounds resemble conventional peptide analogues 
(i.e. 69 for 70) in that they retain critical amino acid chains but differ in that they are 
devoid of both the peptide backbone and amide surrogates. Nicolaou et al later 
reported [67] similar work synthesising mimetics 71 of the potent peptidic antagonist 
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Figure 3: Nicolaou et al non-peptidal peptidomimetics 69 of the peptide hormone somatostatin 
Figure 4: Nicolaou et al non-peptidal peptidominzetics 71 of the potent peptidic antagonist of a/33 
and a/35 pentapeptide cRGDFV 72. 
In 1998 Kessler et al also reported [68] the design and synthesis of new non-
peptide peptidomimetics utilising carbohydrate-based amino acids such as 73 (Figure 
5) as a peptide building block. These sugars carry an amino acid and a carboxylic 










Figure 5: Kessler et al synthesis and design of new non-peptide peptidomitnetics utilising 
carbohydrate based amino acids such as Z.. 
1.3.2 Oligosaccharide Libraries 
Using glycosyl sulfoxide chemistry Kahne et al [69] prepared the first 
carbohydrate library on the solid phase. This library of approximately 1300 1-3 
linked di- and trisaccharides was constructed using the split-mix strategy. 
Employing six distinct monosaccharide acceptors linked to amino functionalised 
Tentagel® resin through an anomeric thioether linker 24 (Scheme 20), 72 different 
di- and trisaccharides were produced by first removal of an acetate protecting group 
to reveal a free hydroxyl group followed by glycosylation with 10 monosaccharide 
and 2 disaccharide sulfoxide donors (see Scheme 20). In each of the 72 different di-
and trisaccharides, the glycosidic bonds were formed with control of both x and f3 
anomeric stereochemistry. Many of the sugar donors and acceptors were azido-
containing sugars. Therefore, further structural diversity was introduced by first 
reduction of the azido sugars to their corresponding amines and then acylation of 
each of the 72 oligosaccharides with 18 different acylating agents. A single step 
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Figure 20: Kahne et al Oligosaccharide library strategy. 
Boons et al later reported [70] a 'two-directional approach' for the synthesis of 
trisaccharide libraries. Initially, a benzyl and tetrahydropyranyl (THP)-protected 
thioglycoside donor was immobilised on a glycine-derivatised Tentagel hydroxyl 
resin via a succinimidyl linker 75 (Scheme 21). The donor was reacted with three 
different glycosyl acceptors (, 77, ) to give, after pooling and splitting, a mixture 
of six different disaccharides (including anomers). After removal of the THP group 
the immobilised disaccharide acceptors 79 were glycosylated with a benzyl-protected 
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thioglycoside donor 80. Cleavage from the resin and deprotection (hydrogenation) 
afforded a library of 12 different trisaccharides. 
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Scheme 21: Boons et al oligosaccharide library strategy. 
More recently Sofia et al [71] have constructed disaccharide libraries using 
phenylsulfenyl 2-deoxy-2-trifluoroacetamido glycopyranoside 81 as the glycosyl 
donor (Scheme 22). 	Solid-phase glycosidations of glycosyl donor 81 with 
glucuronic acid acceptor immobilised on Rink amide resin 82 afforded the 
corresponding fl-glycoside 83 exclusively in high yield. The trifluoroacetamido 
group was removed under mild basic conditions and a 48-member combinatorial 
library was designed around disaccharide 83 using 6 different isocyanates and 8 
different carboxylic acids as elements of diversity. After cleavage using TFA in 
DCM the library products were characterised by LC-MS. The desired derivatised 
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(iii) Ac20, pyr, DMAP, Toluene, DCM; (iv) a) PMe3, THF, EtOH, H20; b) R2NCO, Toluene; (v) 20 % TFA, DCM. 
Scheme 22: Sofia et al disaccharide library synthesis. 
Other recent solid-supported oligosaccharide syntheses that will have an impact 
on future oligosaccharide library design were reported by the groups of Nicolaou 
[72], Danishefsky [73], Schmidt [74] Kobayashi [75] and Wong [62]. 
1.3.3 Glycopeptide Libraries 
Vetter et al constructed a small glycopeptide library (23 members) [58] 
implementing the same procedure as mentioned in section 1.2.3 (Scheme 15). Five 
peptides with Glu(OAU) or Asp(OA11) and permutations of the motif Tyr(tBu)-GIy- 
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Gly-Phe-Leu were synthesised and subsequently coupled to 1-amino-i -deoxy 
derivatives of 18 commercially available saccharides via amide bond construction 
(Scheme 23). Coupling yields of 50-80 % were observed with uncharged 
oligosaccharides and yields of 30-50 % were observed when charged 
oligosaccharides were used. Cleavage of the products from the solid support with 50 
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Scheme 23: Vetter et al 23-component glycopeptide library. 
Another solid-phase glycopeptide library was reported by Chan et al for the 
construction of a library of approximately 350 peptidoglycan monomer analogues for 
screening as inhibitors of bacterial peptidoglycan biosynthesis [76]. The building of 
this peptidoglycan library is strategically different from previously reported solid-
phase glycopeptide syntheses. Unlike typical N-linked glycopeptide syntheses, in 
this construction the carboxylic acid group involved in amide bond formation was 
not part of an aspartic acid or glutamic acid amino acid residue unit and the link to 
the peptide occurred at the peptide terminal amino group (Scheme 24). In this solid 
(I-1 	 1_L_J 
phase library synthesis a series of 12 preconstructed mono- and disaccharide building 
blocks, each containing a muramic acid sugar derivative, were coupled to the 
terminal amino group of each peptide of a small library of 22 peptides linked through 
a chiorotrityl linker. 
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Scheme 24: Chan et al 350 peptidoglycan library synthesis. 
Other groups that have reported the synthesis of glycopeptide libraries include 
the groups of Meldal [77] and Armstrong [78]. 
36 
1.3.4 Monosaccharide libraries 
Sofia et al [79] in 1998 reported on the combinatorial synthesis of encoded 
trifunctionalised saccharide scaffolds termed universal pharmacophore mapping 
libraries (Scheme 25). Construction of the library employed the two-sugar building 
blocks 84 and 85 having a three-point attachment motif comprising a carboxylic acid 
moiety, a free hydroxyl group and a protected amino group. The free carboxylic acid 
was first reacted with eight amino-acid functionalised trityl Tentagel resins, followed 
by carbamate formation at the free hydroxyl site with six isocyanates. Finally, the 
deprotected amino function was acylated with eight different carboxylic acids. 
Deacetylation and cleavage from the resin gave 16 x 48 sub libraries of high purity. 
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(i) 84 or 85. HATU, DIEA, DMF; (ii) R2NCO, DMF Cu(I)CI; 
(iii) a) 20% piperidine in DMF; b) R3COOH, HATU, DIEA, DMF; (iv) 10% TFA, DCE. 
Scheme 25: Sofia et al construction of universal pharmacophore mapping libraries using 
carbohydrates as scaffolds. 
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Kunz et al [80] more recently developed an orthogonal protection procedure 
using the tert-butyldiphenylsilyl, acetate and ethoxyethyl protecting groups, as well 
as a special thioglycoside linker 86 that allowed the individual derivatisation of all 
hydroxyl groups (including those in the anomeric position) in a monosaccharide 
(Scheme 26). The thioglycoside linker served two functions. It allowed the 
immobilisation of the starting material on the solid phase (aminomethyl polystyrene) 
and secondly it could be used as a glycosyl donor for further functionalisation at the 
anomeric position. Initially, the acetate-protecting group was selectively removed 
and the hydroxyl group alkylated with a variety of primary alkyl halides, followed by 
removal of the silyl protecting group and a second alkylation step. Cleavage from 
the resin in the presence of a large excess of alcohol (primary and secondary) lead to 
triply derivatised combinatorial carbohydrate scaffolds as anomeric mixtures (route 
1). Alternatively, the ethoxyethyl protecting group could be removed and the 
resulting hydroxyl function reacted with the alkyl halides or isocyanates. Cleavage 

























(i) a) LiOR, THF, H2O; b) DIEA, HO5u, DCM; (ii) H2NNI-12J-120, DMF; (iii) KOBu, DMF; (iv) RX, DMF; (v) a) TBAF, 
TFIF; b) KOBu, DMF; c) RA, DMF; (vi) PPTS, MeOH, dioxarie; (vii) a) KOBu, DMF; b) R3X, DMF or 
a) R3NCO, DMAP, dioxane; (viii) a) Br2, DCM, DTBP; b) R4011, Et1NBr, DCM, cyclohexane. 
Scheme 26: Kunz et al combinatorial synthesis using carbohydrates as multifunctional chiral 
scaffolds. 
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1.4. A novel Linker for the Attachment of Alcohols to Solid Support 
1.4.1 Background 
As mentioned earlier, carbohydrates are well known in many biological 
systems and consequently there has been much interest in developing new 
methodologies towards the synthesis of carbohydrate molecules, in particular, by the 
use of solid-phase strategies. However, one of the major problems in solid-phase 
carbohydrate synthesis is selective release from the solid support. Linkers are 
required, which are suitable for the attachment and release of substrates and can be 
cleaved under mild and selective conditions. 
Enzyme-cleavable linkers are therefore particularly attractive because cleavage 
might be achieved under mild, neutral and aqueous conditions. Two reports have 
demonstrated that enzymes can be used to cleave molecules from the solid supports 
using phosphodiesterase [81] and an endopeptidase (chymotrypsin) [62]. A major 
drawback of both methods is that the compound released from the solid support 
retains part of the recognition site of the enzyme, i.e. a phosphate ester [81] and a 
peptide with C-terminal phenylalanine residues [62]. Although both 'tags' could in 
principle be cleaved with phosphatases or peptidases respectively, this would 
introduce several additional synthetic steps into the reaction sequences. 
Linker 87 was developed [82] to provide mild, selective release of alcohols, in 
particular carbohydrates, from the solid support. The linker has a pendant 
phenylacetamide, which is the recognition for the enzyme penicillin amidase (EC 
3.5.1.11), a commercially available and widely used enzyme [83]. Penicillin 
amidase is known to catalyse the hydrolysis of a wide range of amines protected as 
the corresponding phenylacetyl derivatives and has been used in synthesis for the 
cleavage of cysteine groups [84]. 
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In development of linker 87 it was first established that penicillin amidase was 
able to cleave phenylacetic acid from a solid support. Model compound 88 was 
synthesised, reduced to compound 89 and was coupled to derivatised aminopropyl 
silica 90 [62, 85] as illustrated in Scheme 27 to give 91. Treatment of this compound 
with penicillin amidase in phosphate buffer released the expected phenylacetic acid, 
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(i) H2, Pt02, THF; (ii) EEDQ, DMF; (iii) Penicillin amidase, phosphate buffer. 
Scheme 27: Initial studies of using penicillin amidase for solid-phase chemistry. 
By way of further illustration using the same enzyme, a soluble form of the 
linker 92 (see Scheme 28) was hydrolysed by penicillin amidase to give the expected 
three products (glucose, phenyl acetic acid and 4-carboxybenzaldehyde, ammonia 
was not monitored). A carbohydrate was attached to the linker exemplifying the 
enzyme hydrolysis of this complex molecule and unnatural substrate for penicillin 
amidase. It was also found that non-enzymatic hydrolysis of 92, using acidic 
conditions, was found to give phenylacetamide rather than phenylacetic acid, thus 
indicating that the linker may also complement the existing range of alcohol linkers. 
Ph 
HNXO 






OH 	 0 
(i) Penicillin amidase, phosphate buffer. 
Scheme 28: Treatment of penicillin amidase to an unnatural substrate and complex molecule 92. 
The synthesis of linker 93 is illustrated in Scheme 29. Suitably substituted 
benzaldehyde could be achieved in several steps, which upon reflux with 
phenylacetamide and benzotriazole in toluene yields benzotriazole adduct 94. It was 
found that displacement of the benzotriazole group could be performed by a good 
nucleophile such as sodium ethyl thiolate, to generate thioamidal 93. The thioether 
could then be displaced by weaker nucleophiles in the presence of thiophilic 
reagents, such as N-iodosuccininiide (NIS), to lead to a variety of structures in good 
yield. Direct displacement of the benzotriazole group with weaker nucleophiles did 
not give similar compounds in acceptable yield. It was also shown that the attached 
R group on 95 could be further modified after coupling. For example, the 
peracetylated glucoside was deacetylated by treatment with triethylamine in 
methanol. The thioethyl group could also be easily displaced by amines, as these 
compounds should equally be susceptible to penicillin amidase hydrolysis, 
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Scheme 29: Synthesis of Linker 93. 
Attachment of the linker onto solid supports could also be achieved. Reduction 
of the azide moiety on 93 to the corresponding amine 87 could be easily performed 
using triphenyiphosphine and water in THE The amine functionality can then be 
used to couple to the commercially available support 'Eupergit' 96 and various other 
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Scheme 30: Attachment of Linker 87 to Solid Support. 
A number of Tentagel® and PEGA® resins were investigated [86] because of their 
compatibility with aqueous reaction conditions and they were reported as being 
suitable for enzyme-catalysed reactions [65]. This identified Tentagel® to be the 
most promising support as this had optimal success in enzymatic cleavage studies, 
although this was found to be only 50 % cleavage at best with typical yields being a 
lot lower. 
1. 4.2 Aim of the present project 
The aim of this work was to continue to use and develop linker 87 in the 
synthesis of carbohydrate derivatives. The work would not only provide an 
investigation into the value of linker 87, but will provide a novel route towards 
biologically important carbohydrate derivatives. The synthetic route to linker 87, 
mentioned previously, had not been performed on a large scale and a major aim of 
this work was to improve and develop the synthesis of linker 87 so that gram 
quantities could be obtained. Similarly the attachment of the linker 87 onto solid 
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supports was achieved with typical yields of only 50 % and so it was hoped that 
other procedures would be found to increase coupling yields. 
In order to investigate the value of linker 87 for the solid-phase synthesis of 
carbohydrate derivatives, appropriate sugar building blocks must also first be 
designed and synthesised which are compatible with the chemical properties of the 
linker. The sugar must be selectively protected to tolerate attachment onto solid 
support (via a free hydroxyl group) and once bound will allow selective deprotection 
so that chemistry can be performed. Our general design for the sugar building blocks 
is shown in Figure 6. 
Free Alcohol group 
facilitating attachment 
onto solid support via 
linker. 
OH 
Protected Alcohol 	 Protected amine: 
groups: potential towards potential towards peptide 
alkylation, sulphonation, 	 NHAc 	 chemistry, alkylation or 
acylation. 	 acylation. 
Figure 6: Framework of the desired sugar building block for Solid-Phase Synthesis. 
The alcohol group at the 6-position was the choice of attachment onto solid support 
since the primary alcohol is the most reactive and has greater availability. An amino 
group at the anomeric centre would allow selective deprotection and N-acylation or 
alkylation and also give a possible alternative route towards glycopeptides. 
It has been envisaged that hydroxyl groups at the 3 and 4-position would be 
protected during the coupling step with groups orthogonal to the amine protection to 
allow further elaboration of the carbohydrate ring with alkylation, sulfation, 
sulfonation and acylation reactions. As mentioned earlier, the use of combinatorial 
chemistry provides a route towards synthesising large collections of compounds 
quickly and it is hoped that this strategy, utilising a suitable sugar building block and 
linker 87, may provide a route towards a library of sugar derivatives. 
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Chapter Two; Results and Discussion 
2.1. Synthesis of Sugar Building Block 106  
2.1.1 introduction 
In order to investigate the value of linker 87 an appropriate sugar building 
block must first be designed and synthesised. As discussed in section 1.4.2, the sugar 
must be selectively protected to tolerate attachment onto solid support and once 
bound will allow selective deprotection so that chemistry can be performed. The 
desired sugar building block 98 is shown in Figure 7 for which N-acetylglucosarnine 
99 could be a suitable starting material. The azido group was chosen for the 
anomeric carbon as this can be easily incorporated into the molecule but would also 
give the desired amine functionality, in one easy step by the action of a number of 
reducing agents [87] including H2 and a catalyst. Acetate protection was chosen as 
protection for the 3, 4-hydroxyl groups in view of the fact that initial studies have 
shown that acetate groups can be removed from sugar substrates whilst attached to 
linker 87 as mentioned in section 1.4.1. It was also envisaged that the selective free 
hydroxyl group at the 6-position would be introduced by the use of a bulky 
protecting group and so sugar 100 was an important synthetic target. 
OH 	 OSiMe2But 	 OH 
AC 	?N 	> AC/ N 	 H ?OH 
NHAc 	 NHAc 	 NHAc 
98 	 100 	 99 
Figure 7: Desired sugar building block 98. 
2.1.2 Synthesis of Sugar 98 
Sugar 100 was synthesised as illustrated in Scheme 31. N-Acetylglucosamine 
99 was treated with acetyl chloride [88] to give selectively the a-glycosyl chloride 
101 by consequence of the anomeric effect [89] in 46 %. During this reaction it is 
thought that the a-peracetylated glucoside is generated first after which the chloride 
displaces the C-i acyl group to give the fl-glycosyl halide (kinetic product) which 
then undergoes anomerisation to the a-glycosyl chloride 101 (thermodynamic 
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product) exclusively. The introduction of the azide moiety was achieved [90] by 
displacement of the chloride with sodium azide under phase transfer catalysis 
conditions to give the desired ,f3-glycosyl azide 102 in 90 %. 
Deprotection of the acetate groups on 102 was achieved by the Zemplén 
procedure [89] which involved using a catalytic amount of sodium methoxide in 
methanol to give 103 in 92 % yield. The primary 6-position was then selectively 
protected using the large bulky tert-butyldimethylsilyl group yielding 104. This step, 
however, was a little more problematic than expected. Conditions first adopted 
involved using tert-butyldimethylsilyl chloride and imidazole as the base in pyridine 
[91]. Surprisingly this proved to be unsuccessful. More forcing conditions were 
therefore attempted using tert-butyldimethylsilyl chloride, triethylamine and 
dimethylaminopyridine in acetonitrile [92] at an elevated temperature as shown in 
Scheme 1. This reaction was successful yielding the expected glycoside 104 in 79 
%. 'H NMR, '3C NMR and mass spectrometry confirmed that the protection at the 
6-position was selective. The 3, 4-hydroxyl groups were again protected as acetate 
groups using acetic anhydride with cold pyridine [93] as the solvent and catalyst to 
give the fully protected /3-glycosyl azide 100 in 98 %. 
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(i) AcCI, RI, 16h; (ii) NaN3, TBAHS, NaHCO3, DCM, RI, 2h; (iii) NaOMe, MeOH, RI, lh; 
(iv) TBDMSCI, DMAP, Et3N, CH3CN, 60 °C, 3h; (v) Ac20, pyr, RI, 16h. 
Scheme 31: Synthesis offully protected f3-glycosyl azide 100. 
The next step of the synthesis was the removal of the silyl-protecting group 
(Scheme 32). Many different reagents have been reported [91, 94-96] to remove 
such a group and a number were attempted. Table 1 summarises the methods 











Scheme 32: Silyl deprotection of 0-glycosyl azide 100. 
De-silylation conditions 	 Observation 
TBAF, THF 	 Decomposition indicated by TLC (several spots) 
AcOH:THF:H20 [3:1:1] 	Acetate migration (confirmed by 'H NMR) to free 6-position 
DDQ, 10 % H20 in CH3CN Acetate migration (confirmed by 'H NMR) to free 6-position 
Table 1: De-silylation conditions attempted and results obtained. 
Employment of a fluoride ion is a well-established method, as the silicon-
fluorine bond is very strong and so a solution of tetrabutylammonium fluoride 
(TBAF) in THF was therefore attempted, adopting literature procedures [91, 94, 95]. 
However, under these conditions the fluoride ion is very basic and the reaction 
revealed several spots upon TLC analysis indicating that decomposition of the sugar 
was occurring. 
A mixture of acetic acid, THF and water in the ratio of 3:1:1 [9 1] was also used 
and this looked more promising upon TLC analysis as only one spot was observed. 
After purification 'H NMR analysis of this compound showed a more complex 
spectrum than expected and indicated that acetate migration was occurring. The 
acidic condition implemented was successful in removing the silyl-protecting group, 
but was also promoting acetate migration at the 4-position to the less sterically 
hindered 6-position. This was apparent by the signal shift of the H-4 proton in the 'H 
NMR spectra to 3.65 ppm. 
Due to lack of success, a far milder method was attempted using DDQ which 
was reported [96] to have success in removing the silyl group. This reaction looked 
hopeful but 1H NMR again indicated that acetate migration was occurring and so the 
sugar building block target that was first intended had to be re-addressed. 
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2.1.3 Synthesis of Fmoc Protected Sugar 19 
It was decided that since the synthesis of sugar 98 was unsuccessful the 
reduction of the azide group and protection of the corresponding amine was the best 
solution to the problem. The protecting group of the amine could be sterically 
hindering for the 6-postion hydroxyl thus reducing the prospect of acetate migration. 
It was also decided that the N-(9-fluorenylmethoxycarbonyloxy) group was the best 
choice of protecting group as this would not only provide steric bulk but would also 
be easily removed. In addition, this group would provide an easy route towards 
calculating the sugar loading on solid-phase by UV detection, which would be useful 
for later studies on solid-phase. 
Reduction of the azide moiety on 100 (see Scheme 33) was therefore performed 
using platinum oxide under an atmosphere of hydrogen [97], which yields the 
corresponding amine. In order to remove the platinum oxide the mixture solution 
was passed through Celite, however, this was unsuccessful. The crude amino 
mixture was therefore dried and used directly in the protection step using N-(9-
fluorenylmethoxycarbonyloxy) succinimide [98] in pyridine to give the fully 
protected glycosylamine 105 in 87 % yield for the 2 steps. Column chromatography 
of glycosylamine 105 removed the platinum oxide retained from the previous step. 
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(i) a)Pt02, H2, THF, RI, 2h; b) FmocOSu, pyr, RI, 16h; (ii)AcOH:T1-IF:H20 (3:1:1), RI, 96h; 
(iii) DDQ, C1-I3CN:H20 (9:1), RI, 48h. 
Scheme 33: Synthesis of 2-acetamido-3, 4-di-Oacetyl-2-deoxy-N-uoren9ylmetho,-ycarbonyl) 
J3-D-glucopyranosylamine 106. 
Deprotection of the 6-position hydroxyl was again attempted using acetic acid, 
THF and water in a ratio of 3:1:1 to give the desired sugar building block j. 
However, it was noticed by TLC that occasionally a secondary similar spot just 
below the original product spot could be observed and this could not be removed. 1H 
NMR of this mixture showed no difference to the desired spectra as this impurity 
was only a trace and it proved very difficult to retrieve. Enough was eventually 
obtained for a 'H NMR which indicated that the impurity was in fact the acetate 
migrated product. Reassuringly, the idea of the bulky amino protecting group 
reduced the acetate migration problem as only a trace was seen if at all, but the acidic 
removal still proved to be a little problematic. DDQ was therefore again attempted 
adopting the same method as before to give the desired sugar building block 106 in 
85%. 
The desired sugar building block 106 was easily synthesised with the last step 
showing no acetate migrated product whatsoever. This reaction also proved to be 
significantly quicker especially in large-scale reactions. The overall synthesis of 
sugar building block 106 can be achieved from N-acetylglucosamine in 23 % and 
was used for synthesising 5-6 gram quantities. 
2.1.4 Summary and Conclusions 
Sugar 106 was synthesised in 8 steps from N-acetylglucosamine in an overall 
yield of 23 % and has proven to be effective enough to generate gram quantities. 
Since this route involves a number of steps, work for the future would be to 
investigate alternative routes which may reduce the number of steps. One possible 
route would be to use lipases to selectively remove the 6-position acetate on sugar 
107 (Scheme 34). 
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Scheme 34: Future work: A possible alternative route towards Sugar 106. 
2.2. Synthesis of Linker 87 
2.2.1 Introduction 
As shown in section 1.4.1, linker 87 has been developed for the attachment of 
alcohols onto solid support and it was the aim of this work to use and develop linker 
87 in the solid-phase synthesis of carbohydrate derivatives. A synthetic route was 
previously developed and used by many, although it had not been performed on a 
large scale (10 g). Since large amounts of the linker were required it was thought 
best to generate as much material as possible and hence develop a synthesis for 
linker 87 that was practical for a larger scale. 
2.2.2 Syntheses and Development of Linker 87 
3-Azidopropylamine 108 (Scheme 35) was synthesised in 81 % as the literature 
procedure described {99} and was carried out on a comparatively large scale (-10 g) 
with no problems. It should be noted that organic azides are extremely unstable or 
explosive under appropriate conditions of initiation and so reactions were performed 
behind blast shields as a precautionary measure. Low molecular weight azides are 
generally more unstable and 50 108 was used immediately where possible. 
Generation of the acid chloride 109 from 4-carboxybenzaldehyde proved more 
problematic as it was difficult to remove excess thionyl chloride completely. The 
consistency of the mixture produced after the reaction was a very thick liquid which 
seemed to retain a lot of the excess thionyl chloride. Although previously no yield 
was quoted for this transformation as the acid chloride was used directly, the yield of 
the subsequent step (i.e. the generation of 110) was only 37 %. An alternative route 
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(i) a) NaN3, H30, 80°C, 16h; b) KOH, Et20, 0°C; (ii) SOCl2, THF, RI; (iii) Et3N, THF, RT, 3h; 
(iv) PhCH2CONH2, BIH, toluene, 140T, 18h; (v) NaSEt, THF, RI, 16h; (vi) PPh3, H20, THF, RI, 16h. 
Scheme 35: Initial synthesis of N-([[4-(3-azidopropylcarbamoyl)phenyl]ethylsulphanyl)methyl)-2-
phenylacetamide 87. 
It was decided for convenience that an amide-coupling reagent would be useful 
rather than generating an activated carboxylic acid. This would therefore reduce the 
number of steps involved and improve the synthesis as a whole. The use of a 
coupling reagent would also have a greater potential to accommodate a large scale, 
which was clearly not the case in the acid chloride route. 	2-Ethoxy-1- 
ethoxycarbonyl- 1, 2-dihydro-quinoline (EEDQ) was chosen as a promoter for the 
coupling reaction (Scheme 36) [101]. 4-Carboxybenzaldehyde was used directly 
with 3-azidopropylamine 108 to generate the desired arnide bond via a mixed 
anhydride mechanism, which after purification using gradient elution flash 











(i) EEDQ, THF, 35 °C, 24h. 
Scheme 36: Generation of the amide bond using EEDQ as the coupling reagent. 
The next step of the synthesis is the generation of the unsymmetrical aminal 4 
and this was achieved using chemistry reported by Katritzky et al [102]. In a one pot 
reaction, aldehyde 110, benzotriazole and phenylacetamide, in equimolar amounts, 
are refluxed in dry toluene for 18 hours. The reaction was presumed to follow the 
mechanism involving formation of a hydroxyalkylbenzotriazole intermediate 111 
(Scheme 37) that subsequently reacts with the amide via an SN1 mechanism. The 
water formed as a side product was removed azeotropically with toluene using a 
Dean-Stark apparatus. TLC analysis of the reaction mixture indicated 3 spots 
corresponding to the starting materials and one new spot, but the reaction never went 
to completion. Increased reaction times were tried in an attempt to drive the reaction 
to completion with no improvement. It was found that the increased reaction time 
had, in fact, a detrimental effect on the reaction resulting in decomposition of the 
product. This was observed by TLC analysis as the product spot became less 
intense. 
As it has already been mentioned, water is formed as a side product resulting 
from the protonation of the hydroxyalkylbenzotriazole intermediate !JJ (Scheme 37) 
with the benzotriazole providing the catalytic amount of protons to induce the 
removal of a water molecule. Given that benzotriazole is not a very strong acid, it 
was decided that an addition of a catalytic amount of further acid be added to the 
reaction in order to catalyse the reaction and hopefully increase yield. Tosic acid 
was therefore added to the reaction mixture in a trace amount resulting in better and 
more reproducible yields of 50-60 % (typical yields are around 50 %). 
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Scheme 37: Proposed mechanism for the formation of 94. 
An additional problem to this reaction step was the purification of 94. Due to 
the many different functional groups present on 94 only a limited range of solvents 
dissolved the product and unfortunately were not suitable for the use in column 
chromatography. Previous purification steps were performed using ethyl acetate and 
petroleum ether 40-60 °C, in a ratio of 2:1, as the solvent system. As these reactions 
were on a much smaller scale, the purification worked with greater success. 
However, on a larger scale this solvent system proved to be unsuccessful with poor 
separation of products. After some time and effort it was found that the best solvent 
system to use was dichioromethane and methanol in a ratio of 98:2. It should be 
noted however, that purification by column chromatography is a limiting factor in the 
synthesis of the linker. 
Displacement of the benzotriazole ring using sodium ethyl thiolate was 
accomplished in 95 % yield to give 93, which can then be treated with 
triphenylphosphine and water in THF to reduce the azide to the corresponding amine 
87. Purification of this compound can be easily achieved by trituration with ether. 
The solid formed is filtered and dried to give a white solid, which is then stirred in 
ether overnight to remove any further impurities. Filtration and drying of the solid 
generates a fine white powder in 88 % yield that is sufficiently pure to use in solid-
phase reactions. Previously, the solid was used after the initial trituration; however, 
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it was found that a second treatment with ether gives purer material and better yields 
in the coupling of the linker onto solid-supports. 
The overall synthesis of linker 87 can be achieved in 21 % from 3-
chioropropylamine hydrochloride and was used in synthesising gram quantities (5-6 
g)- 
2.2.3 Attachment of Linker 87 onto Solid-Support 
The optimal conditions for the attachment of linker 87 on to carboxy-Tentagel® 
112 were employed using 2-(1H-benzotriazole-1-yl)-1, 1, 3, 3-tetramethyluronium 
tetraborate 	(TBTU), 	1 -hydroxybenzotriazole 	(HOBt) 	and 	N, 	N- 
diisopropylethylamine (DIEA) (see Scheme 38) [87]. These three reagents, as well 
as linker 87 and carboxyTentage1® 112, were placed in an isolute tube using DMF 
as the solvent. After 16 h the resin is filtered, washed and dried under vacuo to give 
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(i) TBTU, HOBt, DLEA, DMF, RT, 16h. 
Scheme 38: Attachment of Linker 87 onto Carboxy-Tentagelo using TBTU. 
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The loading of linker-functionalised Tentagel® 113 was determined by treating 
a known amount of resin with acid or base which releases either phenylacetamide or 
phenylacetic acid respectively. As Tentagel®  can be used with aqueous media, 2M 
hydrochloric acid and sodium hydroxide were used. The resin is treated with either 
reagent for 16 h after which the supernatant is neutralised and a known amount is 
injected into the HPLC for analysis. The amount of phenylacetamide or phenylacetic 
acid released is measured using standard calibration curves and this value can be then 
used to calculate the loading of the linker, which can be as high as 0.14 mmol/g (75 
% of initial loading, 0.20 mmol/g), although is typically around 0.09 mmol/g (50 %). 
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Figure 8: a) JR and b) gel-'3 C NMR analysis of linker-functionalised Tentagelo  LU using TBTU as 
the coupling reagent. 
It was later discovered that polystyrene could also be derivatised with linker 87 
using two different coupling methods (Scheme 39) [103]. This resin would provide 
value when the linker is used for non-aqueous chemistry, since the loading is 
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(i) 116, pyr, DCM, RT, 16h; (ii) 87, DIEA, DMF, RT, 16h; (iii) 87, DIC, HOBt, DIEA, DMF, RT, 16h. 
Scheme 39: Coupling of Linker 87 onto carboxy-polystyrene. 
The first coupling method involves activating carboxy-polystyrene 114 as the 
acylfluoride 115. This is easily prepared using cyanuric fluoride [104] and after 
washing and drying the resin, IR analysis of the resin shows an intense peak at 
approximately 1800 cm 1  corresponding to the acyifluoride stretch. This activated 
resin can then be used to couple linker 87 to give linker-functionalised polystyrene 
117 with excellent success and loadings are typically around 0.66 mrnol/g (92 % of 
initial loading, 0.98 mmollg). 
The other method involves the use of 1, 3-diisopropylcarbodiimide (DIC), 1-
hydroxybenzotriazole (HOBt) and N, N-diisopropylethylamine (DIEA) [105]. This 
method is a one-step reaction and loadings obtained are approximately 0.60 mmollg 
(84 % of initial loading, 0.98 mmollg). Since polystyrene is unsuitable for aqueous 
media, loadings for the linker-functionalised polystyrene 117 were not determined 
using 2M hydrochloric acid and sodium hydroxide as performed for the linker-
functionalised Tentagel®  113. Alternatively, a known amount of resin was treated 
with a solution of TFA, DCM and water in a ratio of 9:10:1. The liquid after 
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dissolved up in the HPLC solvent. The amount of phenylacetamide is measured and 
as before is used in calculating the loading. 
Since these methods were so successful for the attachment of linker 87 onto 
carboxy-polystyrene it was thought that these should also be attempted on carboxy-
Tentagel® as the yields obtained using TBTU were still a concerning factor. 
Carboxy Tentagel® was therefore treated with cyanuric fluoride in the hope of 
generating the acylfluoride derivatised resin. An JR of the resin was obtained, 
showing a peak at approximately 1800 cm', however, this was not very intense (see 
Figure 9). This was then treated with linker 87 as mentioned for polystyrene to give 
an overall loading of 0.09 mmol/g (38 % of the initial loading, 0.26 mmol/g). After 
several attempts no increase in yield was obtained and so this method was no longer 
pursued for Tentagel®. 
Figure 9: JR spectra of acyifluoride Tentage1. 
Given the success with the DJC coupling for polystyrene, this method was also 
attempted for Tentagel®  with excellent results. Carboxy-Tentagel®, linker 87, DIC, 
HOBt and DMF were all placed on a blood rotator in an isolute tube for 5 minutes 
prior to adding DIEA. After 16 h the resin was filtered, washed and dried before 
treating a known amount of resin with TFA solution to determine the loading. The 
loading achieved was found to be 0.22 mmol/g (92 % of initial loading, 0.26 
mmol/g), which indicated a far superior method of attachment. JR and gel-'3C NMR 
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Figure 10: a) JR and b) gel-' 3 C NMR analysis of linker-fun ctionalised Tentagelo 17 using DIC as 
the coupling reagent. 
Comparing both sets of spectra, it can be seen that there are fewer impurities in 
the material obtained from the DIC coupling. By comparison of the peak at 
approximately 1650 cm1, which is consequence of the amide bond formed in the 
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coupling step, it can be seen that the material obtained from the DIC coupling shows 
a much more intense peak than that of the TBTU coupling. The gel-13C NMR 
spectrum also shows a major difference between the two methods. The spectrum 
obtained from the TBTU coupling method has many spurious peaks, which have not 
been assigned and are probably due to impurities formed during the poor coupling 
step. 
2.2.4 Summary and Conclusions 
Linker 87 was successfully synthesised in 5 steps from 3-chioropropylamine in 
an overall yield of 21 % in gram quantities. Improvements to the synthesis include 
the use of EEDQ in the amide bond formation step; increased yields in the Katritzky 
reaction by using a catalytic amount of tosic acid and an improved purification step 
of the benzotriazole adduct 94 using DCM:MeOH (98:2). 87 was then attached 
successfully to a both carboxyTentagel® and carboxy-polystyrene using several 
different reagents with DIC giving the highest yields (92 % for Tentagel and 84-92 
% for polystyrene). 
2.3. Syntheses of N-Glycopeptides 
2.3.1 introduction 
Many synthetic routes towards glycopeptides and analogues have been reported 
in the literature. The most general route employed uses glycosylated amino acids for 
stepwise assembly of glycopeptides and so synthetic routes towards these building 
blocks therefore constitute a key success. Recently, an alternative route towards 0-
glycopeptides was reported by Nakahara et al (see section 1.2.2, Schemes 9 and 10), 
which involved the attachment of a sugar molecule to the solid support via a novel 
silyl linker. A key feature of this approach was the feasibility of peptide chain-
elongation at both the N- and C-termini. It has been envisaged that our methodology 
would provide a complementary route towards N-glycopeptides with the direct 
attachment of sugar building block 106 onto solid support via linker 87 (Figure 11). 
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Figure 11: Alternative strategy for the synthesis of N-glycopeptides using sugar 106 and linker 87. 
2.3.2 Attachment of Sugar Building Block 106 onto Linker-functionalised Tentagel 
113 
Initial studies into the attachment of sugar building block 106 onto linker-
functionalised Tentagel® 113, illustrated in Scheme 40, adopted procedures already 
developed by others in the group [82, 86]. Linker-functionalised Tentagel® 113 and 
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sugar 106 were placed in an isolute tube with DMF and N-iodosuccinimide (NIS) 
was then added. The mixture was left overnight to give sugar-functionalised 
Tentagel® 118 after which the resin was filtered, washed and dried. By consequence 
of the sugar furnishing the Fmoc group, the loading of the sugar was determined by 
UV analysis and was found to be a poor 0.02 mmol/g (18 % of initial loading, 0.1 
mmol/g). This method was attempted several times trying to optimise the conditions 
by varying the concentrations and reaction times but no increase in yield was 
achieved. 
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(i) NIS, Solvent, RT, 16h. 
Scheme 40: Coupling of sugar 106 onto Linker-fI€nctionalised Tentagel113. 
A systematic investigation was therefore required and undertaken varying 
several factors involved in the sugar coupling. Many small-scale reactions were 
systematically attempted to try and identify the most promising conditions. In each 
reaction approximately 10-20 mg of linker-functionalised Tentagel® jJ.  (1 eq) and 
sugar 106 (10 eq) were place into an isolute tube with dry solvent and 4A molecular 
sieves. The mixture was left for 30 minutes after which a solution. of N-
iodosuccinimide (4 eq) in the chosen solvent was added. The reaction mixture was 
then left for 16 hours after which the resin was filtered, washed and dried. Again 
loadings were measured by Fmoc analysis. These reactions were repeated several 
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times and Table 2 summarises the conditions attempted quoting the average % 
coupling obtained for each. 
Solvent TfOH used Temp (°C) Time (h) % Coupling 
DMF N 24 16 18 
DMF Y 24 16 24 
DCM N 24 16 18 
DCM Y 24 16 10 
CHCI3  N 24 16 2 
CHCI3  Y 24 16 3 
CH3CN N 24 16 16 
CH3CN Y 24 16 13 
THF N 24 16 10 
THF Y 24 16 40 
Table 2: Results for the coupling of Sugar 106 onto Linker-functionalised Tentagel' 113 varying 
conditions. 
As the initial results using N-iodosuccinimide solution alone did not look 
promising it was decided to try more forcing conditions. Thioglycosides are 
frequently used for glycosidation reactions [106] by activation of the thioethyl group 
followed by displacement with an alcohol. This glycosidation reaction is very 
similar to the coupling being attempted and so these procedures were studied. The 
addition of trifluoromethanesulfonic acid (triflic acid) [107] has often been used in 
these reactions as this reagent favours the generation of the iodonium ion required for 
the activation and release of the thiolate group. The addition of such a reagent was 
therefore also attempted in the sugar coupling reactions. As before, the same scale 
and conditions were tried except a solution of N-iodosuccinimide (4 eq) and triflic 
acid (0.125 eq) was added. Table 2 gives the average % coupling obtained. 
As it can be seen from Table 2, best results were obtained with TI-IF as the 
solvent with a fair 40 % coupling and so it was decided to further optimise this 
coupling. Several different reactions were attempted differing the concentration of 
resin and sugar by varying the amount of THF used. Table 3 summarises the results. 
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Resin (mg) 	Sugar (mg) 	TfOH used 	THF (ml) 	% Coupling 
11.1 10.3 Y 2.0 22 
9.0 9.4 Y 1.0 29 
7.5 9.1 Y 0.7 40 
9.4 11.2 Y 0.5 62 
Table 3: Results for the coupling of Sugar 106 onto Linker-functionalised Tentagelo 113 varying 
concentrations. 
As it can be seen from Table 3, the coupling of sugar 106 onto linker-
functionalised Tentagel®  113 was achieved in good yield using minimal solvent and 
so these conditions were adopted. Unfortunately, the yield of this coupling reaction 
proved to be erratic upon repeated experiments. 
The reaction protocol was therefore investigated in more detail to make the 
outcome of the coupling reaction more reproducible. Whilst looking at the 
procedure, it was noticed that the temperature of the molecular sieves was an 
important factor since the original coupling used sieves direct from the oven. This 
therefore sparked the idea that an increase of temperature was required as this was 
aiding in solubilising sugar 106. As a result of this, the coupling of sugar 106 onto 
linker-functionalised resin 113 was performed at a slightly elevated temperature of 
45 °C to give startlingly consistent results with yields ranging from 60-90 % with 
typical yields of approximately 70 %. 
It was later found that the reaction time for the coupling could be reduced 
considerably to only 2 hours thus reducing the time to generate material for reactions 
to follow. Scheme 41 shows the overall coupling conditions for the reaction which 
will provide consistently good results with slightly elevated yields at larger scales. 
However, it should be noted that the purity of linker-functionalised resin 113 and 
sugar 106 is very important to achieve these yields. Couplings have been performed 
on linker-functional jsed resin 113 that has been stored for some time with reductiOn 
of yields and so the use of freshly prepared resin was preferred. Both the linker-
functionalised resin 113 and the sugar 106 should also be dried in vacuo for 
rii 
approximately 1 hour prior to use and the THF if possible should be obtained freshly 
distilled. 






















(i) NIS, TfOH, THF, 4A ms, 45 °C, 2h (60-90%). 
Scheme 41: Overall conditions for the coupling of Sugar 106 onto Linker-functionalised Tentagel 
113. 
As mentioned earlier the use of polystyrene would also provide value in non-
aqueous chemistry since the loading of the resin is generally higher and because of 
this the coupling of sugar 106 onto linker-functionalised polystyrene fl (Scheme 
42) was also investigated. Table 4 summarises the conditions attempted, which gave 
poor yields, the highest at about 28 %. Conditions adopted from the Tentagel® 
coupling were also unsuccessful and it is postulated that the poor yields are due to 
the difference in the polymer used. Tentagel® resin consists of about 80 % 
polyethylene glycol grafted to cross-linked polystyrene and it is thought that this 
backbone may aid in solubilising sugar 106. The polystyrene resin does not have 
such a backbone and this may be a possible reason for the poor couplings obtained. 
Due to lack of time, this work was not further pursued. 
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(i) NIS, TfOH, solvent (see table), 4A. 
Scheme 42: Coupling of sugar 106 onto Linke r-functionalised polystyrene 117. 
Solvent 	Temp (°C) 	 Time 	 % Coupling 
THF 24 16 28 
THF 45 16 15 
DCM 24 16 9 
CHCI3  24 16 12 
CH3CN 24 16 9 
DMF 24 16 7 
Et20/DCE 24 16 3 
DCMJCH3CN 24 16 6 
Dioxane 24 16 20 
Table 4: Results for the coupling of Sugar 106 onto Linke r-functionalised polystyrene liZ. 
2.3.3 Syntheses of N-Glycopeptides 
Once sugar 106 had been coupled successfully onto Tentagel® via linker 87, 
work on sugar-functionalised Tentagel® 118 began. Since sugar 106 was designed 
with an Fmoc group the most logical step forward was removal of the group and 
further manipulation at the anomeric amine. The importance of different strategies 
towards glycopeptides and the need to synthesise them for further study into their 
biological importance was mentioned in section 1.2. It was therefore decided to 
demonstrate that this methodology has the potential to synthesise glycopeptides and 
by example, the synthesis of N-glycopeptide 119 (Figure 12) was undertaken. The 
peptide attached to the sugar is a fragment of a decapeptide sequence, which is 
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Figure 12: Synthetic target N-glycopeptide 119 from sugar-functionalised Tentagelo j. 
The first important step in the synthesis of N-glycopeptide 119 is the 
attachment of a selectively protected aspartic acid onto the anomeric amine thus 
generating N-acetylglucosamine covalently attached to an asparagine (Asn) side 
chain via a fl-glycosidic linkage 120 (Scheme 43). The Fmoc group on 118 is first 
removed by treatment with 20 % piperidine in DMF for 15 minutes after which the 
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amino-resin 121 is filtered, washed and dried under suction for several minutes. 
TBTU, HOBt and aspartic acid 122a were then placed in the same isolute tube as the 
amino resin 121 and DMF was added. The mixture was left for approximately 5-10 
minutes after which N-methylmorpholine was added and the mixture left on a blood 
rotator for 16 hours. The resin was then filtered, washed, dried and subsequently 
tested by UV analysis to determine the loading of 120a, which was found to be 
approximately 0. 10 mmol/g (60 %). 
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(i) 20% piperidine in DMF, RI, 15 mm ; (ii) TBTU, HOBt, NMM, DMF, RT, 16h. 
Scheme 43: Synthesis of N-acetylglucosamine covalently attached to an asparagine (Asn) side 
chain via a Ji-glycosidic linkage 120. 
This reaction has been performed several times throughout this work and 
typical yields of 60 % were usually obtained with slightly elevated yields when the 
reaction was performed at a larger scale. This yield was accepted to be reasonable 
since it is believed that the anomeric amine is less nucleophilic than compared to free 
amino acids. Again it should be noted that linker 87 is very sensitive to impure 
reagents and so all reagents including the solvents must be extremely pure. When 
reactions were performed with reagents that had been stored for several weeks yields 
were considerably lower. Smaller reagent equivalents with double and triple 
couplings were attempted but also resulted in low yields suggesting decomposition 
during reactions. The tert-butyl ester 122b (Scheme 43) was also coupled using 
these reagents giving comparable results. 120b is very useful as the tert-butyl group 
present can be removed during the acid cleavage step hence further manipulation at 
the C-terminal would be possible. 
120a was then used as a starting material for the synthesis of glycopeptide 112. 
The Fmoc group as previously mentioned was removed using 20 % piperidine in 
DMF (Scheme 44) and the next amino acid, phenylalanine, was coupled using the 
same reagents. Further coupling with Fmoc-protected alanine, threonine, isoleucine 
and valine furnished polymer-bound N-glycopeptide 123. 
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(i) a)20% piperidine in DMF, RT, 15 mm; b) Fmoc-Phe-OH, TBTU, HOBt, NMM, DMF, RT, 16h; (ii)b) a) 20% piperidine in 
DMF, RT, 15 mm; b) Fmoc-Ala-OH, TBTU, HOBt, NMM, DMF, RI, 16h; (iii) a) 20% piperidine in DMF, RT, 15 mm; b) 
Fmoc-Thr(OBu')-OH, TBTU, HOBt, NMM, DMF, RI, 16h; (iv) a) 20% piperidine in DMF, RI, 15 mm; b) Fmoe-Ile-OH, 
TBTU, HOBt, NMM, DMF, RI, 16h; (v) a) 20% piperidine in DMF, RI, 15 mm ; b) Fmoc-Val-OH, TBTU, HOBt, NMM, 
DMF, RI, 16h; (vi) a) 20% piperidine in DMF, RI, 15 mm; b)TFA:DCM:H20 (9:10:1), RI, 16h. 






The synthesis of N-glycopeptide 123 was repeated twice using TBTU and 
HOBt as the coupling reagents. The first attempt was performed on a 60 mg scale, 
which gave only 15 mg of resin at the end of the synthesis with an overall loading of 
0.03 mmol/g for the 6 couplings. The % yield for each coupling and the overall yield 
for the glycopeptide synthesis are given in Graph 1. The synthesis was encouraging 
as the couplings were good to excellent, however the last coupling, which was only 
55 %, was disappointing. 
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Graph 1: % Couplings obtained in the synthesis of N-glycopeptide 123 using TBTU (1 attempt). 
The product obtained on solid support was treated with 20 % piperidine in 
DMF and then cleaved off using TFA:DCM:H20. The cleavage mixture was 
analysed by electrospray mass spectrometry and indicated a peak at 1041 mlz, which 
corresponds to the desired product 119. Removal of the Fmoc group was performed 
prior to the cleavage since it was predicted that the hydrophobic character of the 
peptide would cause problems in the ionising step in the mass spectrometer. The 
cleavage mixture was also analysed by HPLC but unfortunately did not show any 
significant peaks, which was consequence of removing the Fmoc group. It was 
therefore hoped that the synthesis of N-glycopeptide 123 be repeated on a larger 
scale which would provide enough material for a 600 MHz 'H NMR. The Fmoc 







The synthesis of N-glycopeptide 123 was therefore repeated on a 100 mg scale, 
which was enough resin to provide material for a 'H NMR. As seen on Graph 2, the 
% couplings were much lower than previously obtained and the overall loading for 
the 6 couplings was a poor 0.02 mmol/g (NB started with higher initial loading). 
This synthesis did not provide sufficient amount of glycopeptide and was therefore 
not used for further analysis. It was believed that the main problem of this route was 
the quality of the N-methylmorpholine used. It can be comprehended that this 
reagent in time will decompose to other amines and this may have a detrimental 
effect on linker 87. Purification of this reagent was also very time-consuming which 
proved to be inappropriate in this reaction strategy. A much more reliable coupling 
method was therefore required which would give higher yields and would also 
provide an easier route using reagents that would have less chance of affecting linker 
87. 
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Graph 2: % Couplings obtained in the synthesis of N-glycopeptide 123 using TBTU (2' d  attempt). 
In the literature Meldal et al [33] reported that the use of pentafluorophenyl 
esters are very suitable for solid-phase glycopeptide synthesis and show very fast 
coupling rates in the presence of 3, 4-dihydro-3-hydroxy-4-oxo-1, 2, 3-benzotriazine 
(Dhbt-OH). The progress of the acylation can also be followed visually by the 
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displacement of the yellow ion pair formed between Dhbt-OH and resin bound 
amino groups [33]. 
The first synthesis (Graph 3) was performed on a 60 mg scale to test if the 
procedure was successful. This resulted in an overall yield of 59 % (loading = 0.06 
mmol/g), which is considerably higher than that of the TBTU coupling. The 
experimental method is a much easier method and double and triple couplings were 
attempted which showed no detrimental effects towards the synthesis with the result 
of increased yields. 
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Graph 3: % Couplings obtained in the synthesis of N-glycopeptide 124 using pent afluorophenyl 
esters (]t attempt). 
This method therefore proved to be far more beneficial than that of the TBTU 
coupling and so was adopted on a large scale. An acetate capping procedure was 
also introduced so that mixtures of peptide chains were reduced. The overall route 
taken towards N-glycopeptide 124 is shown in Scheme 45. 
The scale used for this synthesis was approximately 0.6 g of sugar-
functionalised Tentagel® 118, which had a loading of 0.11 mmol/g. The initial 
aspartic acid residue was coupled using TBTU as the aspartic acid pentafluorophenyl 
ester was not commercially available and the synthesis of the compound proved to be 
a little problematic. However, the reaction proved successful and aspartic acid 122a 
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coupled to sugar-functionalised Tentagel® 118 in 78 % (Loading = 0.086 mmol/g). 
The acetate capping procedure was then performed and an additional loading was 
measured to check that the linker was stable to the conditions. The Fmoc group was 
then removed and the next amino acid coupled using a solution of Fmoc-amino acid 
pentafluorophenyl ester and Dhbt-OH in DMF. This process was repeated until all 
the amino acids were coupled and graph 4 shows the % couplings obtained for each 
and the overall % coupling. 
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(i) a) 20% piperidine in DMF, RT, 15 mm; b) 122a, TBTU, HOBt, NMM, DMF, RT, 16h; c) Ac20, DMF, RI, 7h; (ii) a) 20% 
piperidine in DMF, RT, 15 mm; b) Fmoc-Phe-OPfp, Dhbt-OH, DMF, RT, 16h; c) Ac20, DMF, RT, 7h; (iii) a) 20% piperidine 
in DMF, RT, 15 mm; b) Fmoc-Ala-OPfp, Dhbt-OH, DMF, RI, 16h; c) Ac20, DMF, RT, 7h; (iv) a)20% piperidine in DMF, 
RI, 15 mm; b)Fmoc-Thr(OBu')-OPfp, DhbtOH, DMF, RT, 16h; c) Ac20, DMF, RI, 7h; (v) a) 20% piperidine in DMF, RI, 
15 mm; b) Fmoc-Ile-OPfp, Dhbt-OH, DMF, RT, 16h; c) Ac20, DMF, RI, 7h; (vi) a) 20% piperidine in DMF, RT, 15 mm; b) 
Fmoc-Val-OPfp, Dhbt-OH, DMF, RT, 16h; C) Ac20, DMF, RT, 7h; (vii) TFA:DCM:H20 (9:10:1), RT, 16h. 
Scheme 45: Overall synthesis of N-glycopeptide 124. 
The overall synthesis was performed in 50 % yield giving a final loading of 0.06 
mrnol/g. The amount of resin collected at the end of the synthesis was approximately 
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Graph 4: % Couplings obtained in the synthesis of N-glvcopeptide 124 using pentafluorophenyl 
esters (2u1 attempt). 
Approximately 13 mg of resin was then treated with TFA:DCM:H20 and the 
cleavage mixture was analysed by HPLC. The HPLC trace obtained is shown in 
Figure 13. The addition of the Fmoc group helped to identify the glycopeptide. 
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Figure 13: HPLC ti-ace of the cleavage mixture from 123. 
An intense peak at 12-13 minutes was observed and presumed to be the desired 
product. The purification looked to be relatively easy and it was therefore decided 
that a 1 ml injection would be tried, collecting the solvent at routine intervals. The 
solvent fractions were collected and re-injected (20 jil) into the HPLC to identify the 
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pure glycopeptide fractions. These were combined, concentrated and re-injected (20 









Figure 14: HPLC trace of the purified N-glycopeptide 124. 
This was then repeated on a larger scale (70 mg), which theoretically gives 5.3 
mg. The cleavage mixture was concentrated to dryness and approximately 8 ml of 
the HPLC solvent was added. Eight (1 ml) HPLC injections were then performed 
collecting the solvent around 10-15 minutes of each. The solvent was combined and 
removed in vacuo to give 3.4 mg of glycopeptide. Problems then arose when trying 
to dissolve the glycopeptide in deuterated solvent. Many solvents were tried 
(CDCH3, CD202, CD3COCD3, CDICN, CD30D, D20) including several mixed 
solvents (CDCH3:CD30D, CD2C12:CD30D, CD3CN:D20), but the glycopeptide 
would not dissolve and therefore dimethylsulfoxide had to be used. Unfortunately 
the 'H NMR obtained showed that the product obtained was not pure and the 
spectrum could not be used for characterisation. This could be due to either the 
inefficiency of the purification step or the purity of the dimethylsulfoxide used. 
A similar amount of resin (79 mg) was also treated with the TFA solution so 
that the purification may be performed again, but unfortunately the glycopeptide 
cleavage mixture would not dissolve up in the HPLC solution as it did before. Extra 
solvent was added to help dissolve the solid but had little effect. This therefore 
indicated that the HPLC purification adopted using H20 and acetonitrile was not 
reliable and so an alternative solvent system must be found. This could not be 
achieved due to time constraints. A mass spectrum of the pure glycopeptide was 
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obtained (Figure 15) however, indicating a peak at 1263 mlz that corresponds to the 
Fmoc-glycopeptide 124 with sodium and potassium adducts at 1285 and 1301 mlz 
respectively. Other significant peaks are 1221 [MH-OAc], 1155 [MHtOBn] and 
1113 [MHtOBnOAc]. Sodium and potassium adducts are also present for these. 
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Figure 15: Mass spectrum of purified N-glycopeptide 124. 
2.3.4 Summary and Conclusions 
Sugar 106 was successfully linked through the 6-hydoxyl group onto 
carboxy-Tentagel® via linker 87 in 60-90 % yield. Extension of the glycosidic amino 
group on 118 provides a route towards the synthesis of N-glycopeptides and has been 
demonstrated in the synthesis of N-glycopeptide 124 using two different routes. The 
use of pentafluorophenyl esters and Dhbt-OH has proved to be the most successful 
route towards 124 with excellent couplings being obtained. A mass spectrum of N-
glycopeptide 124 did indicate that the synthesis was successful. 
Future work would be to synthesise sugar-functionalised resin 120 and 
demonstrate that this methodology provides a route towards manipulation of the C-
terminal of glycopeptides. Particularly useful should be the C-terminal tert-butyl 
protecting group 120b. 
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2.4. Library Syntheses 
2.4.1 Introduction 
The use of combinatorial chemistry provides a route towards synthesising large 
collections of compounds quickly and thus has the potential to speed up biological 
testing and identifying new drug candidates. It has been envisaged that removal of 
the acetate groups on sugar 118 and further elaboration of the free hydroxyl groups 
produced with alkylation, sulfonation, sulfation or acylation reactions, is a potential 
strategy to synthesise such a library. 
2.4.2 Library Synthesis 
Previous work in our group indicated that the acetate groups on a sugar can be 
successfully removed using triethylamine [87] and linker 87 was stable to the 
conditions adopted. It was therefore hoped that sugar-functionalised Tentagel® 118 
(Scheme 46) would be treated with triethylamine to give the free hydroxyl groups 
which would then be used in esterification reactions to generate a small library. 
Before this could be performed the base labile Fmoc group had to be exchanged to a 
more robust protecting group. A N-benzyloxycarbonyl (Cbz) protecting group was 
the chosen amino protection, as this group is known to be relatively acid and base 
stable but may be cleaved by catalytic hydrogenolysis [108]. 	The N- 
benzyloxycarbonyl protecting group also contained a benzene ring which would aid 
in detection. 
Sugar-functionalised Tentagel® 125 was synthesised using 118 (Scheme 46). 
Deprotection of the amine was first undertaken using 20 % piperidine in DMF and 
then the amine generated was treated with N-benzyloxycarbonyl succinimide and 
triethylamine in DMF to give 125. 
(iii) 	 OH 
ACO 	
(01 (ii) AcO
9\ NHCb 	AcOAco~ NHCb 
NHAc 	 NHAc 	 NHAc 
118 	 125 	 126 
(i) 20% piperidine in DMF, RT, 15 mm ; (ii)Cbz-05u, Et3N, DMF, RT, 16h; (iii) TFA:DCM:H20 (9:10:1), RT, 16h. 
Scheme 46: Synthesis of sugar-functionalised Tentage1/. 
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Determination of the loading was achieved by comparing HPLC standards with 
the cleavage mixture and Scheme 47 shows the synthetic route towards the HPLC 
standard 126. Sugar 105, which was previously synthesised, was used as the starting 
material and first treated with 20 % piperidine in acetonitrile to remove the Fmoc 
group. The corresponding free amine was then treated with N-benzyloxycarbonyl 
succinimide in pyridine [109] to give 127. The last step is removal of the silyl-
protecting group which was achieved using DDQ to give the desired HPLC standard 
126 in an overall yield of 73 % from saccharide 105. 





NHAc 	 NHAc 	 NHAc 
105 	 127 	 126 
(I) 20% piperidine in CH1CN, RI, 5 mm; (ii) Chz-OSu, pyr, RT, 16h; (iii) DDQ, DCM:I-120 (20:1), RI, 16h. 
Scheme 47: Synthesis of HPLC standard 126. 
Sugar-functionalised Tentagel®  125 was treated with TFA:DCM:H20 solution 
and the cleavage mixture analysed by HPLC using water (plus 0.1 % TFA) and 
acetonitrile in a ratio of 60:40 as the solvent system. A typical trace of the cleavage 
mixture is shown in Figure 16. The peak at approximately 3.4 minutes corresponds 
to the phenylacetamide, produced by consequence of the linker, and the desired peak 
at 4.2 minutes was also observed. The loading of the sugar-functionalised Tentagel® 
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Figure 16: HPLC trace of the cleavage mixture from 125. 
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The next stage was to remove the acetate groups on sugar-functionalised 
Tentagel® 125 (Scheme 46), which had previously been shown to be successful using 
a solution of triethylamine in methanol. As shown in Scheme 48, sugar-
functionalised Tentagel® 125 was treated with a solution of triethylamine in 
methanol overnight and was then filtered, washed and dried to yield 128. 
OH 
ACO O\ N 	0)HO NHCb 	
(ii) 	
HO NHCb 
NHAc 	 NHAc 	 NHAc 
125 	 128 	 129 
(i)Et3N, MeOH, RI, 16h; (ii)TFA:DCM:1-{20 (9:10:1), RI, 16h. 
Scheme 48: Synthesis of sugar-functionalised Tentagel'5 128. 
Again an HPLC standard had to be synthesised in order to determine the loading of 
the sugar and Scheme 49 shows the synthetic route adopted towards sugar 129. 
Previously synthesised sugar 102 was used as the starting material and was treated 
with platinum oxide under an atmosphere of hydrogen to reduce the azide to the 
corresponding amine. 	The amine produced was then treated with N- 
benzyloxycarbonyl succinimide in pyridine to give 130, which was then treated with 
a solution of sodium methoxide in methanol to give the desired HPLC standard j. 





(ii) AcO_O\NHCbz 	 HO HO NHCb 
NHAc 	 NHAc 	 NHAc 
102 	 130 	 129 
(i)1-1 2, Pt02, THF, RI, 2h; (ii) Cbz-OSu, pyr, RT, 16h; (iii) NaOrvle, MeOH, RI, lh. 
Scheme 49: Synthesis of HPLC standard sugar 129. 
128 which was then treated with TFA:DCM:H20 solution and the cleavage mixture 
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Figure 17: HPLC trace of the cleavage mixturefrom 128. 
As the synthesis of sugar-functionalised Tentagel® 128 looked promising, the 
reaction was repeated several times so that sufficient material was obtained and 
esterification reactions could be performed. Unfortunately, during these reactions it 
became apparent that the reactions performed gave very erratic results and so were 
unreliable. Typical yields were found to be 30-50 %, which were not efficient 
loadings for our purposes. It was therefore decided that as an alternative route 
towards sugar-functionalised Tentagel® 128, sugar 129 be coupled directly to linker-
functionalised Tentagel®  113 in the hope of achieving elevated loadings. It was 
presumed that the free sugar would couple preferentially to the primary hydroxyl 
group since this has the highest availability and is the most reactive site. 
Sugar 129 was therefore coupled onto linker-functionalised Tentagel®  113 to 
give 128 adopting the same coupling protocol mentioned for sugar 106 and is shown 
in Scheme 50. THF was again used as the solvent. The loading however had to be 
determined by HPLC analysis of the cleavage mixture. Typical yields for this 
coupling were found to be 30-50 % (0.06-0.10 mmol/g), and this was sufficient to 
perform esterification reactions. It should be noted however, that this reaction has 
not been optimised due to time constraints but has the potential to give better yields 
than actually quoted. 
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(i) NIS, TfOH, THF, 45 °C, 2h, 
Scheme 50: Coupling of sugar 129 onto linker-Jiinctionalised Tentagel'' 113. 
The sugar-functionalised Tentagell(D  128 generated was then used to perform 
esterification reactions to produce a small library of compounds. The conditions 
adopted have previously been successful in generating esterified libraries [1 10] and 
Scheme 51 illustrates the synthetic approach implemented towards 131. 
T 	 T 
NHC HOT 	 0)H/Ri,2{ 
	
LC-MS 
NHAc 	 NHAc 








(i) RCO2H, DMAP, EDCI, DCM, RI, lôh; (ii) TFA:DCM:H20 (9:10:1), RT, 16h. 
Scheme 51: Esterification reaction used in the synthesis of the small library. 
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A solution of carboxylic acid, 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide 
hydrochloride (EDCI) and dimethylaminopyridine (DMAP) in DCM was first 
prepared and left for 10 minutes after which was added to 20-30 mg of dried resin 
128 and the mixture was placed on a blood rotator overnight. The resin was then 
filtered, washed and dried and then treated with TFA:DCM:H20 solution. The 
cleavage mixture of each reaction was analysed by LC-MS, which provided enough 
information to indicate if the reactions were successful. Table 5 summarises the 
details and results. 
RCO2H 	HPLC Peaks 	MS data 	 Observation 
(mins) 	 (m/z) 
phCH2CO2Ha 12.07 473.19, 495.31 (M + Na), Monosubstituted 
518.37 (M + K4). 
4.26 135.55, 176.62 (M + K). Phenylacetamide 
3.26 355.17, 377.30 (M + Na). Unsubstituted 
MeOC6H4CH2CO2Hb 12.63 503.31, 525.30 (M + Nat), Monosubstituted 
548.49 (M + K4). 
4.25 135.55, 176.62 (M + K). Phenylacetamide 
3.18 355.05, 377.18 (M + Na4). Unsubstituted 
H0C6H4CH2CO2Hc 6.90 624.59. Disubstituted adduct 
5.75 489.33, 511.20 (M + Na'), Monosubstituted 
534.63 (M + K). 
4.23 135.55, 176.62 (M + K4). Phenylacetamide 
3.18 355.17, 377.18 (M + Nat). Unsubstituted 
CH3C6H4CH2CO2Hd 19.70 487.30, 509.29 (M + Na), Monosubstituted 
532.47 (M + K4). 
4.24 135.55, 176.62 (M + K). Phenylacetamide 
3.18 355.17, 377.18 (M + Na). Unsubstituted 
C1C6H4CH2CO2He 4.23 135.55, 176.74 (M + K4). Phenylacetamide 
3.18 355.17, 377.18 (M + Na4). Unsubstituted 
'see Figure 18, b  see Figure 19, C  see Figure 20, d see Figure 21, 'see Figure 22 (see appendix A3). 
Table 5: LC-MS data: Reaction products of 128 with different acids RCO2H. 
None of the reactions performed had gone to completion (i.e. diesterification) 
with substantial amounts of starting material being observed. It can also be 
concluded that for most of the reactions only the monosubstituted products were 
obtained with substitution probably occurring at the 3-position as this is the more 
reactive hydroxyl group. Another possibility for this monosubstitution is that the 4-
position hydroxyl is sterically hindered. This is only speculation and has not been 
proven as there was not sufficient material to obtain a 'H NMR. Optimisation of 
these reactions was also attempted using double couplings but HPLC analysis 
indicated that this had a detrimental effect with loss of product. However, this work 
does provide a good example of the utility of LC-MS in solid-phase reactions and 
this methodology may be a possible route towards selective esterifications. 
2.4.3 Summary and Conclusions 
While initial studies have shown the potential of sugar 118, attempts to 
synthesise suitable sugar-functionalised resins from 128 for library synthesis have 
proved problematic. This is thought to be due to the linker instability. As an 
alternative route, sugar 129 was synthesised from N-acetylglucosamine in 5 steps. 
The saccharide was attached onto carboxy-Tentagel® via linker 87 although the 
coupling has not been optimised. Resin bound 128 was then used in initial studies 
into esterification reactions by means of a small library. The material generated on 
solid-support was cleaved off and analysed by LC-MS. Initial work has shown that 
esterifications on sugar-functionalised Tentagel®  128 were possible although were 
not high yielding. It has also been observed that the method adopted only produced 
monoesterified products which may prove significant. 
Work for the future would be to optimise the coupling of sugar 129 to linker-
functionalised Tentagel® 113 and determine fully the point of attachment onto the 
linker. Further investigation into the esterification reaction would also be undertaken 
as to establish if the reaction is selective with other carboxylic acids. 
*3 
Chapter Three; Experimental 
3.1. General Experimental 
3.1.1 Instrumentation 
'H NMR and '3C NMR spectra were recorded on Bruker AC200, Bruker 
AC250, Varian Gemini 200 and Varian Inova 600 instruments. 
Fast atom bombardment (FAB) mass spectroscopy was performed using a 
Kratos MS50TC instrument and electron impact (El) mass spectroscopy was carried 
out on a Finnigan 4500 instrument. Electrospray (ESI) and atmospheric pressure 
chemical ionisation (APCI) mass spectrometry was carried out on a Micromass 
Platform II instrument. 
Infrared spectroscopy was performed on a Perkin Elmer Paragon 1000 FT-W 
spectrometer. 
UV/Visible spectroscopy was performed on either a Hewlett Packard 8453 or 
Unicam UV2-100 UV/Visible spectrometer. 
Optical rotations were performed on an Optical Activity Ltd. Polarimeter. 
Elemental analysis was carried out using a Perkin Elmer 2400 CHN Elemental 
Analyser. 
Melting points were measured on a Gallenkamp melting point apparatus and 
were uncorrected. 
A Stuart Scientific SB! 360° blood rotator or a New Brunswick Scientific G76 
gyrotary shaker was used to agitate solid supported samples at room temperature. 
3.1.2 Solvents and Reagents 
All reagents were standard laboratory grade and used as supplied unless 
otherwise stated. Where a solvent is described as dry either it was purchased as 
anhydrous grade or was distilled prior to use. 
CarboxyTentagel® resin and carboxy-polystyrene resin were purchased from 
NovaBiochem and amino acids were purchased from Bachem. 
3.1.3 Chromatography 
Analytical TLC was performed on aluminium-backed plates coated with silica 
gel 60F254  (Merck: layer thickness of 0.2 mm). For flash chromatography, silica gel 
C60 (Merck: 40-60 jim) was used with a variety of different sized columns. The 
components were identified by UV light (254 nm); a solution of 1 % sulphuric acid, 
2 % p-anisaldehyde in ethanol was used for sugar derivatives; a solution of 0.3 % 
ninhydrin, 3 % acetic acid in butan-1-ol was used for amino derivatives. 
3.1.4 High Performance Liquid Chromatography (HPLC) 
The HPLC system used consisted of a Waters 486 Tuneable Absorbance 
Detector and a Waters 600E Pump and Controller together with the Waters 
Millennium Chromatography manager. The column employed was a Phenomenex® 
Sphereclone RP-18 (5 jim particle size) with dimensions 25 cm by 4.6 mm. A 
Spherisorb ODS 2 (5 jim particle size) pre-column of length 1 cm was also used. 
Samples were injected via either a 20 jil  loop (analytical) or 1000 jil  (preparation) 
and a flow rate of 1 ml/min was used for elution. A wavelength of 215 nm was used 
for sample detection. 
Phenylacetic acid and phenylacetamide were initially monitored using a 
gradient elution (Method 1, Table 6). Four standards were run for phenylacetic acid 
and phenylacetamide and a calibration curve constructed for each. 
This method was later replaced by an isocratic system (Method 2; 0.1 % TFA 
in H20: MeCN [70:30] for 15 mm). Analysis of sugar derivatives was performed 
using either Method 2 or Method 3, 0.1 % TFA in H20: MeCN [60:40] for 10 mm. 
Method 3 was used for the purification of glycopeptide 124. When using the 
isocratic systems two standards were run before and one after for each compound 
and a standard concordancy test was carried out. 
Mins 	I 25mIV1, p116.5 I Acetonitrile 
buffer soV 
0 100 0 
15 85 15 
20-30 60 40 
40-55 100 0 
Table 6: Method 1, HPLC gradient elution. 
EIR 
3.2. General Protocols 
3.2.1 Resin washing protocol 
A wash cycle for c.a. 20-50 mg of resin typically consisted of THF (5-10 ml x 
2), DMF (5-10 ml x 2), DMF:MeOH (1:1) (5-10 ml x 2), DMF (5-10 ml x 2), THF 
(5-10 ml x 2) and DCM (5-10 ml x 2). 
3.2.2 Fmoc analysis 
Dry resin (c.a. 5-15 mg) was accurately weighed in a 5 or 10 ml volumetric 
flask. Freshly prepared 20 % piperidine in DMF solution was added up to the mark 
and the mixture sonicated for 10 mm. The supernatant was transferred to a UV cell 
and the absorbance at X = 301 nm recorded. The loading was then calculated using 
Equation 1 derived from the Beer-Lambert Law using the extinction coefficient ( @ 
301 nm = 7800 M' cm') quoted by Sabatier et al [111]. 
Equation 1:L=AxV/7.8xin, 
Where: L = loading of Fmoc in mmol/g resin 
A = absorbance at X = 301 nm 
V = volume in ml 
in = mass of resin in mg 
3.2.3 JR Spectroscopy 
Where an JR spectrum of the resin has been taken several drops of DCM have 
been added to facilitate swelling and the resin placed between two NaCl plates after 
which the spectra are run as normal. 
3.2.4 Gel Phase '3CNMR 
Gel Phase 1 3 C NMR were carried out by swelling the resin in DCM-D2. Where 
'3c NMR data is quoted in the experimental section, diagnostic peaks have been 
assigned sometimes with the aid of relevant solution spectra. These peaks may also 
have been observed in the presence of other peaks that were not assigned and may be 
due to the resin impurities generated by reaction on solid support or the desired 
compound itself. 
3.2.5 Cleavage Protocol for Compounds Synthesised on Solid Support 
Dry resin (c.a. 5-15 mg) was accurately weighed out and treated with a solution 
of TFA:DCM:H20 [9:10:1] (0.5-1.5 ml) and the mixture was left for 16 h after which 
the resin was filtered off and washed with DCM (2 ml x 2) or successively with 
DCM (2 ml), MeOH:DCM 1:1 (2 ml) and DCM (2 ml). The filtrate and washings 
were combined and the solvent was removed in vacuo to dryness. 
3.3. Nomenclature of Resin Bound Compounds [112] 
When naming compounds in accordance with IUPAC recommendations it is 
necessary to determine the characteristic group to be cited as a suffix or as a 
functional class name. For example, in the case of 87 the amide functional group 
takes precedence over the thioether and amine functional groups. The amide is 
therefore the characteristic group and the other groups are substituents that are 
described using prefixes in alphabetical order. Hence, 87 is called N-({ [4-(3-. 







When naming resin bound compounds the resin has been considered to be the 
functional class name. 	For example, 4- { [ethylsulphanyl-N-(2-phenylacetyl)] 
aminomethyl } -benzamidopropylamido Tentagel® 113. 
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3.4. Calculations of Yields for Resin Bound Compounds 
3.4.1 Calculation of the loading for the attachment of 87 to carboxy resin 
The residue collected after the cleavage protocol was dissolved up in the HPLC 
solvent (method 2) and injected into the HPLC. The area of the peak obtained is 
compared to standard phenylacetamide sample areas and the loading is calculated 
(see appendix Al for example calculation). 
3.4.2 Calculation of the loading for the attachment of sugar 106 and amino acids 
The loading was determined using Fmoc analysis (see section 5.1.2) and was 
calculated directly using equation 1 (see appendix A2 for example calculation). 
3.4.3 Calculation of the loading for the generation of sugar 125 and 128 on 
Tenta gel® 
The residue collected after the cleavage protocol was dissolved in the HPLC 
solvent (method 2 for 125 and method 3 for 128) and injected into the HPLC. The 
area of the peak obtained is compared to areas of 126 and 129 standards and the 
loading is calculated (see appendix Al for example calculation). 
3.4.4 Calculation of weight gain or loss 
When calculating the yield for resin bound compounds the weight increase or 
loss incurred during the reaction is taken into account, however this is more 
significant for polystyrene than Tentagel®,  but is carried out nonetheless. For 
example, in the case of coupling 87 to carboxy-polystyrene (Scheme 53), the loading 
of the carboxy functionality on carboxy-polystyrene was typically 0.98 mmollg. If 
complete coupling is achieved 1 g of resin will increase in weight by (0.98 x 10 3 x 
molecular weight of linker 87 - weight of 1 x 0 and 2 x H =) 0.36 g. The loading of 
linker would therefore be (1/1.36) x 0.98 = 0.72 mmol/g. If cleavage from the resin 
ON 
indicates a loading of 0.68 mmol/g then (0.68/0.72 x 100) % coupling has been 
achieved. 
0 	 0 
1j J h jNH2  HO 
Ph( 
0 SEt 87 
0 	 0 
Ph( Y-e PS 
o SEt 
Scheme 53: Coupling of 87 to carboxy-polystyrene. 
91 
3.5. Safety Notice 
Please note "many compounds of both organic and inorganic derivation, which 
contain the azide function, are unstable or explosive under appropriate conditions of 
initiation" [113]. Appropriate precautions should be taken when handling such 
compounds. Organic azides synthesised in this project were reduced using PPh3/H20 
in THF prior to disposal. 
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3.6. Synthesis of Sugar Building Block 106 
3.6.1 2-Acetamido-3, 4, 6-tri-O-acetyl-2-deoxy-a-D-glucopyranosyl chloride 101 
[88] 
ACO- 
Dried 2-acetamido-2-deoxy- a-D-glucopyranose (10.09g. 45.6 mmol) was 
added gradually to acetyl chloride (20 ml, 281.3 mmol) with good stirring and the 
mixture stirred at RT for 16 h after which chloroform (80 ml) was added and the 
solution poured with vigorous stirring onto ice (80 g) and water (20 ml). The organic 
layer was treated with ice-cold saturated sodium bicarbonate solution (80 ml) and the 
mixture separated. The organic layer was dried over anhydrous MgSO4, filtered, 
concentrated in vacuo and dry diethyl ether (100 ml) added. After 12 h the solid was 
collected, washed with dry diethyl ether (30 ml x 2) and dried under suction for 5 
min to yield the crude product. The solid was purified using flash chromatography 
(EtOAc) to yield title compound 101 (7.61 g, 46 %) as a white solid, mp 124-126 °C 
(Lit. mp 127-128 °C [88]) (Found: C, 46.22; H, 5.62; N, 3.68. C14H20C1N08 requires 
C, 45.97; H, 5.51; N, 3.83 %); [a]D +1 14.6 (c 1.02, CHCI3) (Lit. [a]D  +109.7-118.0°  
[88]); l)max (Nujol)/cm' 3241.7 (NH), 1741.2 (CO), 1642.9 (NHCO), 723.1 (CC!); 
(250 MHz; CDCI3) 6.16 (1H, d, J 3.7, 1-H), 5.94 (1H, d, J 8.8, NH), 5.31 (1H, dd, J 
9.4 and 10.1, 3-H), 5.18 (1H, dd, J 9.4 and 9.7, 4-H), 4.51 (1H, ddd, J 3.7 8.8 and 
10. 1, 2-H), 4.25 (2H, in. 5-H, 6a-H), 4.09 (1H, dd, J 3.5 and 13.6, 6b-H), 2.07 (3H, s, 
OCOCH3), 2.02 (6H, s, OCOCH3), 1.96 (3H, s, NHCOCH3); 	(63 MHz) 171.3 
170.4 170.0 169.0 (CO), 93.5 (C 1), 70.7 (CS), 69.9 (C3), 66.8 (C4), 61.0 (C6), 53.2 
(C2), 22.9 (NHCOCH3), 20.5 20.4 (OCOCH3); mlz (FAB) 368 (MNa, 14.4 %), 366 
(MH, 21.2 %), 330 (MHtC1, 22.8 %) (Found: MH 366.09510. C13H21C1N08  
requires 366.09557). 
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3.6.2 2-Acetamido-3, 4, 6-tri-O-acetyl-2-deoxy-f3-D-glucopyranosyl azide 102 [90] 
OAc 
AT—-0 AcO 	 N3  
NHAc 
To a solution of 101 (5.08 g, 13.9 mmol), tetrabutylammonium hydrogen 
sulphate (4.72 g, 13.9 mmol) and sodium azide (3.61 g, 55.5 mmol) in DCM (50 ml) 
was added saturated sodium bicarbonate solution (50 ml). The two-phase mixture 
was stirred vigorously at RT for 2 h after which TLC (EtOAc) indicated complete 
transformation of the starting material. Ethyl acetate (500 ml) was added, the 
organic phase separated and successively washed with saturated sodium bicarbonate 
solution (50 ml), water (50 ml x 2) and brine (50 ml). The combined organic extracts 
were dried over anhydrous Na2SO4, filtered and evaporated under reduced pressure 
to yield the crude product. The solid was recrystallised using chloroform and hexane 
to afford the title compound 102 (4.65 g, 90 %) as a white solid, mp 165-166 °C (Lit. 
mp 166-167 °C [90]) (Found: C, 45.40; H, 5.51; N, 14.90. C14H21N408 requires C, 
45.16; H, 5.41; N, 15.05 %); [aID —40.0 (c 1.09, CHCI3) (Lit. [ct]D —43.00 [901); Umax 
(Nujol)/cm 1 3275.3 (NH), 2127.7 (N3), 1748.6 (CO), 1657.0 (NHCO); 	(250 
MHz; CDCI3) 6.12 (1H, d, J 9.0, NH), 5.25 (1H, dd, J 9.4 and 10.5, 3-H), 5.08 (1H, 
dd, J9.4 and 10.0, 4-H), 4.78 (1H, d, J9.2, 1-H), 4.25 (1H, dd, J4.8 and 12.4, 6b-H), 
4.13 (1H, dd, J 2.4 and 12.4, 6a-H), 3.90 (1H, ddd, J 9.0 9.2 and 10.5, 2-H), 3.80 
(1H, ddd, J 2.4 4.8 and 10.0, 5-H), 2.07 (3H, s, OCOCH3), 2.01 (3H, s, OCOCH3), 
2.00 (3H, s, OCOCH3), 1.95 (3H, s, NHCOCH3); 	(63 MHz) 170.8 170.6 170.5 
169.2 (CO), 88.2 (Cl), 73.7 (C5), 72.0 (0), 68.0 (C4), 61.7 (C6), 53.9 (C2), 23.1 
(NHCOCH3), 20.6 20.5 20.4 (OCOCH3); m/z (FAB) 373 (MH, 31.4 %), 330 (MHt 
N3, 34.1 %), 150 (MHt-N3 OAc x 3, 46.0 %), 43 (Ac, 86.8 %) (Found: MH 
373.13475. C14H22N408 requires 373.13594). 
3.6.3 2-Acetamido-2-deoxy- -D-glucopyranosyl azide 103  
OH 
HO 
HO 	 N3  
NHAc 
To a solution of 102 (4.51 g, 12.1 mmol) in dry methanol (40 ml) was added 
sodium methoxide in methanol (0.5 M, 7 ml) and the mixture stirred at RT for 1 h 
after which TLC (CHCI3:MeOH:H20 [3:1:1]) indicated complete transformation of 
the starting material. The reaction mixture was filtered through cation ion-exchange 
resin and the methanol evaporated in vacuo to yield the crude product. The solid was 
recrystallised using acetone to afford the title compound 103 (2.75 g, 92 %) as a 
white solid, mp 145-147 °C (Found: C, 36.64; H, 5.80; N, 21.04. C8H14N405.H20 
requires C, 36.36; H, 6.10; N, 21.20 %); [c]D -41.5 (c 1.01, MeOH); Umax 
(Nujol)/cm 1 3280.5 (NH OH), 2116.4 (N3), 1640.0 (NHCO); 4j (250 MHz; CD30D) 
4.60 (1H, d, J 9.2, 1-H), 4.02 (1H, dd, J 1.8 and 12.1, 6a-H), 3.80 (1 H, dd, J 5.5 and 
12.1, 6b-H), 3.77 (1H, dd, J 9.2 and 10.1, 2-H), 3.47-3.38 (3H, m, 3-H 4-H 5-H), 
2.09 (3H, s, NHCOCH3); t5c (63 MHz) 169.6 (CO), 88.6 (C 1), 79.5 (CS), 74.0 (C3), 
70.2 (C4), 60.9 (C6), 54.9 (C2), 23.1 (NHCOCH3); m/z (FAB) 247 (MH, 100.0 %), 
204 (MHtN3, 50.6 %), 186 (MHtN3 H20, 43.6 %) (Found: MH 247.10524. 
C8H15N405 requires 247.10424). 
3.6.4 2-Acetamido-6-tert-O-buiyldimethylsilyl-2-deoxy- -D-glucopyranosyl azide 104 
OSiMe2But 
HO 
HO 	 N3  
NHAc 
To a solution of 103 (0.10 g, 0.4 mmol) and tert-butyldimethylsilyl chloride 
(0.08 g, 0.5 mmol) in pyridine (3 ml) was added imidazole (0.05 g, 0.8 mmol) and 
the mixture left stirring for 18 h after which TLC (EtOAc:MeOH [9:1]) indicated no 
transformation of starting material. DMAP (0.05 g, 0.4 mmol) was then added and 
the mixture was left for a further 16 h after which TLC indicated no reaction. 
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HO N3  
NHAc 
A mixture of 103 (2.30 g, 9.3 mmol), tert-butyldimethylsilyl chloride (2.80 g, 
18.6 mmol), triethylamine (2.6 ml, 18.6 mmol), and DMAP (0.68 g, 5.6 mmol) in 
acetonitrile (46 in]) was heated to 60 °C for 3 h after which TLC (EtOAc) indicated 
all the starting material was consumed. Water (100 ml) was then added and the 
product extracted using chloroform (100 ml x 3). The organic layer was dried over 
anhydrous MgSO4 and evaporated in vacuo to yield yellow oil. The product was 
purified using flash-column chromatography (EtOAc:MeOH [9:1]) to yield the title 
compound 104 as a white solid (2.65 g, 79 %), mp 141-142 °C (Found: C, 46.46; H, 
8.06; N, 15.25. C14H28N405Si requires C, 46.65; H, 7.83; N, 15.54 %); [aID  —53.3 (c 
1.04, CHC13); 'Omax (Nujol)/cm 1 3276.0 (NH OH), 2116.8 (N3), 1659.8 (NHCO), 
1075.2 779.0 (SiO), 837.1 (Si(CH3)2); Jjj (250 MHz; CDCI3) 7.06 (1H, d, J7.5, NH), 
5.19 (IH, d, J 3.4, 3-OH), 4.60 (1H, d, J 8.8, 1-H), 4.37 (in, d, J 3.4, 4-OH), 3.92 
(1H, dd, J4.0 and 11.5, 6a-H), 3.85 (1H, dd, J4.5 and 11.5, 6b-H), 3.61 (2H, in, 2-H 
3-H), 3.42 (2H, in, 4-H 5-H), 2.02 (3H, s, NHCOCH3), 0.89 (9H, s, C(CH3)3), 0.09 
(6H, s, Si(CH3)2); & (63 MHz) 172.3 (CO), 88.2 (Cl), 77.3 (C5), 74.3 (C3), 71.6 
(C4), 63.5 (C6), 55.4 (C2), 25.7 (C(CH3)3), 23.2 (NHCOCH3), 18.2 (C(CH3)3), -5.4 
(Si(CH3)2); mlz (FAB) 361 (MH, 95.4 %), 318 (MHtN3, 75.4 %), 187 (MHtN3  
OTBDMS, 37.6 %),131 (OTBDMS, 21.7 %),115 (TBDMS, 79.3 %),42 (N3,81.1 
%) (Found: MH 361.19145. C14H29N405Si requires 361.19072). 
3.6.6 	2-Acetamido-3, 	4-di-O-acelyl-6-O-tert-butyldimethylsilyl-2-deoxy--D- 
glucopyranosyl azide 100  
OSIMe2Bu' 
AcO 
AcO 	 N3  
NHAc 
To a cooled solution of 104 (3.14 g, 8.7 mmol) in pyridine (70 ml, 870 mmol) 
was added drop wise acetic anhydride (82 ml, 870 mmol). After 1 h the mixture was 
allowed to warm to RT and the mixture left stirring for 16 h after which TLC 
(EtOAc) indicated complete transformation of starting material. The reaction 
mixture was then poured onto ice (200 g) and chloroform (500 ml) and separated. 
The organic layer was washed with saturated sodium bicarbonate solution (150 nil x 
3) and water (200 ml x 3), dried over anhydrous MgSO4 and the solvent azeotroped 
with toluene in vacuo to yield the crude product. The product was purified using 
flash-column chromatography (EtOAc:Hex [7:3]) to yield the title compound 100  
(3.79 g, 98 %) as a white solid, mp 175-176 °C (Found: C, 48.93; H, 7.52; N, 12.35. 
C18H32N407Si requires C, 48.63; H, 7.26; N, 12.60 %); []D  —30.0 (c 1.04, CHCI3); 
Umax (Nujol)/cm 1 3261.3 (NH), 2118.5 (N3), 1750.2 (CO), 1656.6 (NHCO), 1037.5 
779.6 (SiO), 838.2 (Si(CH3)2); 41 (250 MHz; CDC13) 5.99 (1H, d, J 9.1, NH), 5.19 
(1H, dd, J 9.4 and 9.4, 3-H), 5.04 (1H, dd, J 9.4 and 9.5, 4-H), 4.64 (1H, d, J 9.3, 1-
H), 3.92 (1H, ddd, J 9.1 9.3 and 9.4, 2-H), 3.73 (1H, dd, J 2.6 and 11. 5, 6a-H), 3.70 
(1H, dd, J4.7 and 11.5, 6b-H), 3.61 (1H, ddd, J2.6 4.7 and 9.5, 5-H), 2.01 (6H, s, 
OCOCH3), 1.99 (311, s, OCOCH3), 1.95 (3H, s, NHCOCH3), 0.86 (911, s, C(CH3)3), 
0.03 (6H, s, Si(CH3)2); & (63 MHz) 171.1 170.4 169.0 (CO), 88.2 (Cl), 76.6 (CS), 
72.5 (C3), 68.4 (C4), 62.1 (C6), 53.8 (C2), 25.6 (C(C113)3), 23.1 (NHCOCH3), 20.5 
(OCOCH3), 18.2 (C(CH3)3), -5.5 (Si(CH3)2); m/z (FAB) 446 (MH, 16.9 %), 402 
(MHtN3, 69.1 %), 282 (MHtN3 OAc x 2, 56.0 %), 115 (TBDMS, 78.2 %), 43 
(Ac, 100 %), 42 (N3, 10.5 %) (Found: MH 445.21040. C18H33N407Si requires 
445.21185). 
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3.6.7 2-Acetamido-3, 4-di-O-acetyl-2-deoxy--u-glucopyranosyl azide 98 
OH 
AcO 
AcO 	 N3 
NHAc 
To a stirred solution of 100 (0.10 g, 0.2 mmol) in dry THF (2 ml) was added 
drop wise TBAF in THF (1 M, 0.5 ml) and the mixture was left stifling at RT for 2 h 
after which TLC (EtOAc) indicated many spots forming. 
3.6.8 2-Acetamido-3, 4-di-O-acetyl-2-deoxy- f3-D-glucopyranosyl azide 98 
OH 
ACO ? N  AcO 
NHAc 
To 100 (90.0 mg, 0.2 mmol) was added a solution of AcOH:THF:H20 [3:1:1] 
(3 ml) and the mixture left stirring at RT for 2 h after which TLC (EtOAc) indicated 
complete transformation of the starting material. Water (20 ml) was then added and 
the product extracted using chloroform (20 ml x 3). The combined organic extracts 
were washed with saturated sodium bicarbonate solution (10 ml x 2) and water (10 
ml x 2), dried over anhydrous MgSO4 and concentrated to give an oil which was 
purified using flash-column chromatography (EtOAc:Hex [9:1]) to yield a white 
solid which was identified as 2-acetamido-3, 6-di-O-acetyl-2-deoxy-3-D-
glucopyranosyl azide (0.05 g, 78 %); AH (250 MHz; CDCI3 CD30D) 5.10 (in, dd, J 
9.4 and 9.7, 3-H), 4.81 (1H, d, J 9.4, 1-H), 4.54 (1H, dd, J 2.0 and 12.1, 6a-H), 4.35 
(111, dd, J 5.3 and 12.1, 6b-H), 3.88 (1H, dd, J 9.4 and 9.4, 2-H), 3.77 (111, m, 5-H), 
3.65 (1H, dd, J 9.7 and 10.0, 4-H), 2.11 (6H, s, OCOCH3), 2.07 (3H, s, OCOCH3), 
2.02 (3H, s, NHCOCJJ3); & (63 MHz) 171.8 171.7 170.7 (CO), 88.4 (C 1), 75.9 (C5), 
74.6 (C3), 68.4 (C4), 62.9 (C6), 53.7 (C2), 23.1 (NHCOCH3), 20.8 20.7 20.5 
(OCOCH3). 
3.6.9 2-Acetamido-3, 4-di-O-acetyl-2-deoxy- 3-D-glucopyranosyl azide 98 
OH 
AcO 
AcO 	 N3  
NHAc 
To a stirred solution of 100 (88.9 mg, 200.0 pmo1) in 10 % water in acetonitrile 
(1 ml) was added a solution of DDQ (4.5 mg, 19.8 tmol) in 10 % water in 
acetonitrile (1 ml) and the mixture was stirred at RT for 16 h after which TLC 
(EtOAc) indicated that all the starting material had been consumed. The solvent was 
then removed in vacuo to yield the crude product and was purified using flash-
column chromatography (EtOAc) to yield white solid which was identified as 2-
acetamido-3, 6-di-O-acetyl-2-deoxy-f3-D-glucopyranosyl azide (59.8 mg, 83 %); 4 
(250 MHz; CDC13 CD30D) 5.10 (1H, dd, J 9.4 and 9.7, 3-H), 4.81 (1H, d, J 9.4, 1-
H), 4.54 (1H, dd, J 2.0 and 12.1, 6a-H), 4.35 (1H, dd, J 5.3 and 12.1, 6b-H), 3.88 
(1H, dd, J 9.4 and 9.4, 2-H), 3.77 (1H, in, 5-H), 3.65 (lB. dd, J 9.7 and 10.0, 4-H), 
2.11 (6H, s, OCOCH3), 2.07 (3H, s, OCOCH3), 2.02 (3H, s, NHCOCH3); 	(63 
MHz) 171.8 171.7 170.7 (CO), 88.4 (Cl), 75.9 (C5), 74.6 (C3), 68.4 (C4), 62.9 (C6), 
53.7 (C2), 23.1 (NHCOCH3), 20.8 20.7 20.5 (OCOCH3). 
3.6.10 2-Acetamido-3, 4-di-O-acetyl-6-O-tert-butyldimethylsilyl-2-deoxy-N-(fluoren-
9-yl-methoxycarbonyl)- f3-D-glucopyranosylamine Jj 
OSiMe2But 
AcO 
AcO 	 NHFmoc 
NHAc 
Under an atmosphere of hydrogen, 100 (2.76 g, 6.2 mmol), platinum (TV) 
oxide (0.23 g, 1.0 mniol) and dry THF (65 ml) were stirred vigorously at RT for 2 h 
after which TLC (EtOAc) indicated that all the starting material had been consumed 
and the reaction mixture was concentrated in vacuo to yield yellow oil that contained 
platinum oxide. This crude amino sugar mixture and N-(9-fluorenylmethoxy 
carbonyloxy) succinimide (2.50 g, 7.4 mmol) were then dissolved in anhydrous 
pyridine (40 ml) and the reaction was stirred at RT for 16 h after which TLC 
(EtOAc) indicated complete transformation of the amino starting material. The 
solvent was azeotroped with toluene in vacuo and the product purified using flash-
column chromatography (CHCI3:EtOAc [8:2]) to yield the title compound 105 (3.44 
g, 87 %) as a white solid, mp 182-183 °C (Found: C, 61.56; H, 6.85; N, 4.32. 
C33H44N209Si requires C, 61.85; H, 6.92; N, 4.37 %); [x]D —6.3 (c 1.03, CHCI3); 
Umax (Nujol)/cm' 3306.0 (NH), 1745.0 (CO), 1703.0 (NHCOO), 1658.6 (NHCO), 
1047.3 740.2 (SiO), 838.4 (Si(CH3)2); 	(250 MHz; CDCI3) 7.74 (2H, d, J 7.3, H), 
7.55 (2H, d, J 7.3, Har), 7.37 (2H, dd, J 7.3, Ha,), 7.28 (2H, dd, J 7.3, Har), 6.37 (1H, 
d, J 8.9, NHFmoc), 6.17 (1H, d, J 7.4, NHAc), 5.13 (111, dd, J 9.5 and 9.6, 3-H), 
5.07 (1H, dd, J 9.5 and 9.6, 4-H), 4.88 (1H, dd, J 8.9 and 9.5, 1-H), 4.29 (1H, t, J 8.0, 
CHCH20), 4.19 (211, d, J 8.0, CHCH20), 4.14 (111, m, 2-H), 3.76 (1H, dd, J 2.5 and 
11.3, 6a-H), 3.66 (1H, dd, J 3.8 and 11.3, 6b-H), 3.59 (1H, m, 5-H), 2.06 (311, s, 
OCOCH3), 2.01 (311, s, OCOCH3), 1.95 (3H, s, NHCOCH3), 0.86 (9H, s, C(CH3)3), 
0.02 (6H, s, Si(CH3)2); & (63 MHz) 171.9 171.5 169.0 155.8 (CO), 143.7 143.4 
141.1 (C r), 127.6 127.0 125.0 119.8 (CH,,,), 82.4 (Cl), 75.8 (CS), 73.4 (C3), 68.4 
(C4), 67.4 (CHCJ-120), 62.2 (C6), 53.1 (CHCH20), 46.7 (C2), 25.7 (C(C113)3), 23.0 
(NHCOCH3), 20.6 (OCOCH3), 18.2 (C(CH3)3), -5.5 (Si(CH3)2); m/z (APCI+) 641 
(MH, 100.0 %), 419 (MH-Fmoc, 84.2 %), 402 (MHtNHFm0c, 80.4 %), 281.3 
(MHtNHFmocOTBDMS, 74.0%); m/z (FAB) 641 (MH, 1.3 %) (Found: MH 
641.28788. C33H44N209Si requires 641.28944). 





To 105 (0.26 g, 0.4 mmol) was added a solution of AcOH:THF:H20 [3:1:1] (10 
ml) and the mixture left stirring at RT for up to 96 h until TLC (EtOAc) indicated 
complete transformation of the starting material. Water (50 ml) was then added and 
the product extracted using chloroform (SO ml x 3). The combined organic extracts 
were washed with saturated sodium bicarbonate solution (50 ml x 2) and water (50 
ml x 2), dried over anhydrous MgSO4 and concentrated to give the crude product 
which was purified using flash-column chromatography (EtOAc:Hex [9:1]) to yield a 
white solid (0.19 g, 91 %); 	(250 MHz; CDCI3 CD30D) 7.64 (2H, d, J 7.4, H r), 
7.46 (2H, d, J7.4, Har), 7.28 (2H, dd, J7.4, Hat),  7.19 (2H, dd, J7.4, Har), 5.06 (1H, 
dd, J 9.5 and 9.6, 3-H), 4.93 (1H, dd, J 9.3 and 9.5, 4-H), 4.82 (1H, d, J 9.8, 1-H), 
4.23 (2H, d, J7.5, CHCH20), 4.11 (1H, t, J7.5, CHCH20), 4.03 (1H, in, 2-H), 3.53 






To a stirred solution of 105 (1.35 g, 2.1 mmol) in 10 % water in acetonitrile (16 
ml) was added a solution of DDQ (0.05 g, 0.2 mrnol) in 10 % water in acetonitrile (2 
ml) and the mixture was stirred at RT for up to 48 h until TLC (EtOAc) indicated 
that all the starting material had been consumed. The solvent was then removed in 
vacuo to yield the crude product and was purified using flash-column 
chromatography (CHCI3:MeOH [98:2]) to yield the title compound 106 (0.94 g, 85 
%) as a white solid, mp 227-228 °C (Found: C, 61.56; H, 5.90; N, 4.95. C27H30N209 
requires C, 61.59; H, 5.74; N, 5.23 %); [a]u +6.8 (c 1.01, DMSO); 'Umax (Nujol)/cm' 
3313.8 (NH OH), 1744.2 (CO), 1707.2 (NHCOO), 1659.7 (NHCO); 	(250 MHz; 
CDC13 CD30D) 7.64 (2H, d, J 7.4, H), 7.46 (2H, d, J 7.4, H), 7.28 (2H, dd, J 7.4, 
H), 7.19 (2H, dd, J 7.4, H), 5.06 (111, dd, J 9.5 and 9.6, 3-11), 4.93 (1H, dd, J 9.3 
and 9.5, 4-H), 4.82 (1H, d, J 9.8, 1-H), 4.23 (2H, d, J 7.5, CHCH20), 4.11 (1H, t, J 
7.5, CHCHO), 4.03 (111, in, 2-H), 3.53 (3H, in, 5-H 6a-H 6b-H), 1.94 (6H, 5, 
OCOCH3), 1.84 (3H, s, NHCOCH3); &, (63 MHz) 172.0 170.9 169.9 156.5 (CO), 
143.3 143.2 140.9 (C), 127.5 126.7 124.7 119.6 (CH), 81.2 (Cl), 75.4 (C5), 73.1 
(C3), 68.5 (C4), 67.1 (CHCH20), 60.7 (C6), 52.2 (CHCH20), 46.5 (C2), 22.3 
(NHCOCH3), 20.2 (OCOCH3); mlz (APCI+) 527 (MH, 100.0 %), 305 (MH-Fmoc, 
101 
40.2 %), 288 (MH-N11Fmoc, 72.5%), 83 (C5H50, 100 %); m/z (FAB) 527 (MH, 
4.1 %) (Found: MH 527.20082. C27H31N209 requires 527.20296). 
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3.7. Synthesis of linker 87 
3.7.1 3-Azidopropylamine 108 [99] 
H2NN3 
A solution of 3-chioropropylamine hydrochloride (10.01 g, 77.0 mmol) and 
sodium azide (11.99 g, 184.8 mmol) in water (75 ml) was stirred at 80 °C for 16 h 
after which the solution was cooled to 0 °C and diethyl ether (100 ml) added. 
Potassium hydroxide (5.18 g, 92.4 mmol) pellets were then added gradually so that 
the solution temperature did not exceed 10 °C. The aqueous layer was washed with 
diethyl ether (100 ml x 2), saturated with sodium chloride (20.04 g, 0.34 mol) and 
then washed again with diethyl ether (50 ml x 3). The combined organic extracts 
were then dried over anhydrous K2CO3  and the solvent evaporated in vacuo using a 
cold-water bath to yield 108 as a pale yellow oil (6.21 g, 80 %), bp 50-52 °C @ 20 
mmHg (Lit. bp 45-50 °C @ 15 mmHg [99]); Umax (neat)/cm' 3370.0 (NH2), 2939.0 
2869.3 (CH), 2098.3 (N3); & (250 MHz; CDCI3) 3.41 (2H, t, J 6.8, CH2N3), 2.77 
(2H, t, J 6.8, CH2NH2), 1.70 (2H, tt, J 6.8, CH2CH2CH2), 1.57 (2H, s, NH2); i5c (63 
MHz) 48.9 (CH2N3), 39.1 (CH2NH2), 32.1 (CH2CH2CH2); mlz (El) 101 (MH, 3.6 
%), 84 (MHtNH2, 6.5 %), 71 (N3CH2CH2 , 20.5 %), 56 (N3CH2 , 27.2 %), 44 
(NH2CH2CH2 , 82.7 %), 42 (N3, 41.4 %), 30 (NH2CH2 , 100.0%). 
3.7.2 N-(3-Azidopropyl)-4-formylbenzamide jJ [82] 
0 
-te  
To a stirred solution of 4-carboxybenzaldehyde (9.98 g, 66.5 mmol) in dry 
THF (60 ml.) was added thionyl chloride (15 ml, 199.5 mmol) and the reaction 
mixture was left stirring until HC1 gas evolution ceased. Once cooled to RT the 
solvent was removed in vacuo to yield the crude acid chloride. This was then 
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dissolved in dry THF (40 ml) and added to a cooled solution of 108 (6.20 g, 61.9 
mmol), triethylamine (11.1 ml, 80.0 mmol) and dry THF (40 ml) and the reaction 
mixture left stirring at RT (EtOAc:Hex [2:1]) until TLC indicated complete 
transformation of starting material. Water (200 ml) was then added and the aqueous 
layer was washed with chloroform (200 ml x 2), saturated with sodium chloride (20.5 
g, 0.15 mmol) and then washed again with chloroform (100 ml x 2). The combined 
organic extracts were then dried over anhydrous Na2SO4 and the solvent evaporated 
in vacuo to yield pale yellow oil. The product was purified using flash-column 
chromatography (EtOAc:Hex [2:1]) to yield the title compound 110 (5.74 g, 37 %) as 
a pale yellow syrup; max  (Nujol)/cm 1 3286.6 (NH), 2162.4 (N3), 1697.9 (COil), 
1633.2 (NHCO); 41 (250 MHz; CDC13) 10.00 (1H, s, COH), 7.87 (4H, s, CHEW), 7.02 
(1H, s, CONHCH2), 3.53 (2H, dt, J 6.5, CONHCH2), 3.41 (2H, t, J 6.5,CH2N3), 1.87 
(2H, tt, J 6.5, CH2CH2CH2). 
3.7.3 N-(3-Azidopropyl)-4-formylbenzamide IIQ 
0 
-le  
To a solution of 108 (3.70 g, 37.0 mmol) and 4-carboxybenzaldehyde (5.55 g, 
37.0 mmol) in dry THF (60 ml) was added EEDQ (10.98 g, 44.4mmol) in the course 
of a few minutes. The reaction mixture was stirred at 35 °C for 24 h after which TLC 
(EtOAc:Hex [2:1]) indicated complete transformation of the starting material and 
water (150 ml) was added. The product was extracted using chloroform (150 x 3 
ml), the combined organic extracts washed successively with 1 M hydrochloric acid 
(100 ml x 2), water (100 ml), brine (100 ml x 2) and again water (100 ml x 2), dried 
over anhydrous MgSO4 and the solvent removed in vacuo to yield pale yellow oil 
containing solid. The product was purified using flash-column chromatography 
(gradient elution used starting with Hex:EtOAc [9:1] increasing to Hex:EtOAc [1:1]) 
to yield the title compound 110 (5.24 g, 61 %) as a white solid, mp 41-42 °C (Found: 
C, 56.90; H, 4.98; N, 23.88. C11H12N402 requires C, 56.89; H, 5.21; N, 24.12 
tII 
Umax (Nujol)/cm' 3286.6 (NH), 2162.4 (N3), 1697.9 (COH), 1633.2 (NHCO); tij  
(250 MHz; CDC13) 10.00 (1H, s, COH), 7.87 (4H, s, CH), 7.02 (111, s, CONHCH2), 
3.53 (2H, dt, J 6.5, CONHCH2), 3.41 (2H, t, J 6.5,CH2N3), 1.87 (2H, tt, J 6.5, 
CH2CH2CH2); & (63 MHz) 191.5 (COH), 166.5 (CONH), 139.4 137.9 (C), 129.6 
127.5 (CH), 49.3 (CH2N3), 37.8 (CONHCH2), 28.4 (CH2CH2CH2); mlz (FAB) 233 
(MH, 5.6 %), 105 (C6H4COH, 7.1 %) (Found: MH 233.10274. C11H13N402 
requires 233.103851). 
3.7.4 	N-([[4-(3-Azidopropylcarbamoyl)phenyl]benzotriazol] -yl)methyl)-2- 
phenylacetamide 94 [82] 
Ph (N 
A solution of 110 (5.50 g, 23.7 mmol), benzotriazole (2.82 g, 23.7 mmol), 
phenylacetamide (3.20 g, 23.7 mmol) and tosic acid (0.10 g, 0.5 mmol) in dry 
toluene (150 ml) was refluxed for 18 h after which TLC (EtOAc:Hex [2:1]) indicated 
complete transformation of starting material. Dean-Stark apparatus was employed to 
remove the water side-product. The toluene was removed in vacuo to yield yellow 
oil containing solid and the product purified using flash-column chromatography 
(DCM:MeOH [98:2]) to yield the title compound 94 (5.54 g, 50 %) as a white solid, 
mp 163-164 °C (Found: C, 64.38; H, 4.93; N, 23.86. C25H24N802 requires C, 64.09; 
H, 5.16; N, 23.92 %); Umax (Nujol)/cm' 3275.1 (NH), 2112.1 (N3), 1649.5 (NHCO), 
1627.2 (NHCO); 9fi (250 MHz; DMSO-D6) 10.06 (1H, d, J 7.0, NHCI-{Bt), 8.57 (1H, 
t, J 6.8, CONHCH2), 8.08 (1H, d, J 8.3, CH of bt), 8.00 (1H, d, J 8.3, CHBt), 7.89 
(1H, d, J 8.3, CHofbt), 7.87 (2H, d, J 8.3, CH,,,), 7.54 (1H, ddd, J 1.0 7.0 and 8.3, 
CH of bt), 7.48 (211, d, J 8.3, CH), 7.42 (1H, ddd, J 1.0 7.0 and 8.3, CH of bt), 
7.24 (5H, in, PhCH2), 3.68 (111, d, J 14.2, PhCH), 3.59 (1H, d, J 14.2, Phd]), 3.38 
(2H, dt, J 6.8, CONHCH2), 3.31 (2H, t, J 6.8,CH2N3), 1.76 (211, tt, J 6.8, 
105 
CH2CH2CH2); & (63 MHz) 170.9 165.8 (CO), 145.3 139.2 135.6 135.1 132.0 (C), 
129.2 128.3 127.8 127.7 126.9 126.7 124.5 119.4 111.2 (CH",), 65.0 (NHCHBt), 
48.6 (PhCH2), 41.7 (CH2N3), 36.8 (CONHCH2), 28.5 (CH2CH2CH2); mlz (FAB) 469 
(MH, 22.2 %), 350 (MW-Bt, 100.0 %), 232 (MHtBtPhCH2CO, 44.9 %), 223 
(MHtCONH(CH2)3N3, 12.6 %), 120 (BtH, 19.4 %) (Found: MH 469.21080. 
C25H25N802 requires 469.21080). 
3.7.5 	N-(([4-(3-Azidopropylcarbamoyl)phenyl]ethylsulphanylJmethyl)2 





A solution of 94 (2.34 g, 5.0 mmol) in dry THF (50 ml) was added drop wise to 
a stirred suspension of ethylthiolate sodium salt (0.90 g, 10.5 mmol) in THF (10 ml) 
and the overall solution was left stirring at RT for 2 h after which TLC (EtOAc:Hex 
[2:1]) indicated that all the starting material was consumed. Water (150 ml) was then 
added and the product extracted using chloroform (200 x 3 ml), the aqueous layer 
saturated with sodium chloride (40.04 g, 0.68 mol) and the product again extracted 
with chloroform (100 x 2 ml). The combined organic extracts were dried over 
Na2SO4 and the solvent removed in vacuo to yield the title compound 93 (1.96 g, 95 
%) as a white solid, mp 172-173 °C (Found: C, 61.29; H, 6.12; N, 17.02. 
C21H25N502S requires C, 61.58; H, 6.10; N, 16.77 %); u1 	(Nujol)/cm 1 3285.7 
(NH), 2095.6 (N3), 1639.7 (NHCO); 	(250 MHz; CDC13) 9.15 (lH, d, J 9.5, 
NHCHSEt), 8.52 (1H, t, J 6.8, CONHCH2), 7.81 (2H, d, J 8.4, CH",), 7.52 (2H, d, J 
8.4, CH,,,), 7.28 (5H, m, PhCH2), 6.21 (1H, d, J 9.5, CHSEt), 3.58 (1H, d, J 13.7, 
PhCII), 3.52 (1H, d, J 13.7, PhCH), 3.43-3.28 (4H, m, CH2N3 and CONHCH2), 2.58 
(1H, dt, J7.4 and 12.7, SCHCH3), 2.42 (1H, dt, J7.4 and 12.7, SCHCH3), 1.77 (2H, 
tt, J 6.8, CH2CH2CH2), 1.15 (3H, t, J 7.4, SCH2CH3); &c (63 MHz) 170.0 166.0 
(CO), 143.0 136.3 134.0 (Car), 131.0 129.5 129.1 128.3 127.4 126.6 (CH,,,), 54.6 
OU 
(CHSEt), 48.6 (Phd 2), 42.2 (CH2N3), 36.7 (CONHCH2), 28.5 (CH2CH2CH2), 24.8 
(SCH2CH3), 14.7 (SCH2CH3); m/z (FAB) 412 (MH, 5.1 %), 350 (MHtSEt, 32.7 
%), 307 (MHtSEtN3, 22.1 %), 232 (MHtSEtPhCH2CO, 15.6 %) (Found: MH 
412.18251. C21H26N502S requires 412.18072). 
3.7.6 	N-(([4-(3-Aminopropylcarbamoyl)phenyl]ethylsulphanyljmethyl)-2 





To a solution of 93 (2.10 g, 5.1 mmol) in THF (60 ml) and water (1 ml) was 
added triphenylphosphine (1.61 g, 6.1 mmol) and the overall mixture stirred at RT 
for up to 72 h until TLC (EtOAc) indicated complete transformation of starting 
material. The reaction mixture was then concentrated in vacuo to give an oil after 
which diethyl ether (100 ml) was added and the walls of the flask scratched to 
facilitate crystal nucleation. The solid formed was filtered, stirred in ether (100 ml) 
for 16 h, filtered again and the solid dried to yield the title compound 87 (1.73 g, 88 
%) as a white powder, mp 133-135 °C (Found: C, 65.17; H, 6.91; N, 10.62. 
C21H27N302S requires C, 65.43; H, 7.06; N, 10.90 %); Dmax (Nujol)/cm 1 3282.8 
(NH), 1641.5 (NHCO); 	(250 MHz; CD30D), 7.86 (2H, d, J 8.3, CHaJ), 7.60 (2H, 
d, J 8.3, CH), 7.39 (5H, m, PhCH2), 6.34 (1H, s, CHSEt), 3.71 (1H, d, J 13.9, 
PhCH), 3.65 (1H, d, J 13.9, PhCII), 3.52 (2H, t, J 6.8, CONHCH2), 2.79 (2H, t, J 6.8, 
CH2NH2), 2.70 (1H, dt, J 7.4 and 20.3, SCHCH3), 2.54 (1H, dt, J 7.4 and 20.3, 
SCHCH3), 1.84 (2H, tt, J 6.8, CH2CH2CH2), 1.30 (3H, t, J 7.4, SCH2CH3); 	(63 
MHz) 164.0 160.4 (CO), 135.1 127.5 125.8 (C), 120.6 120.2 119.1 118.5 (CH), 
47.1 (CHSEt), 34.3 (PhGH2), 30.3 (CONHCH2),  28.9 (CH2NH2), 23.9 
(CH2CH2CH2), 16.9 (SGH2CH3), 5.6 (SCH2CH3); m/z (FAB) 386 (MH, 26.5 %), 
307 (MH-SEt-NH2, 29.6 %) (Found: MH 386.18958. C21H28N302S requires 
386.19023). 
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3.7.7 Preparation of 4-[[Ethylsulphanyl-N-(2-phenylaceiyl)]aminomethyl)-
benzamidopropylamido Tentagelo 113 using TBTU [86] 
0 	 0 
H 
0 Ph,,yNye  
0 SEt 
Carboxy-Tentagel® (0.50 g, 0.20 mmol/g), 87 (0.23 g, 0.6 mmol), TBTU (0.42 
g, 1.3 mmol), HOBt (0.18 g, 1.3 mmol) and DMF (3 ml) were placed on a blood 
rotator in an isolute tube (10 ml) for 5 min after which DIEA (0.23 ml, 1.4 mmol) 
was added and the mixture left on the blood rotator for 16 h. The resin was then 
filtered, washed and dried in vacuo yield the title compound 113 (50 %, 0.09 
M11101/9); Umax (DCM)/cm 1 3515.8 (NH), 2954.6 (CH), 1651.4 (NHCO); &c (63 
MHz, DCM-D2) 170.2 (CO), 142.7 135.4 134.5 (C), 129.3 128.8 127.5 127.1 126.7 
(CH), 55.6 (CHSEt), 42.9 (PhCH2), 36.2 (CONHCH2), 36.1 (CH2NHCO), 29.6 
(CH2CH2CH2), 25.5 (SCH2CH3), 14.7 (SCH2CH3). 
3.7.8 Preparation of 4-([Ethylsulphanyl-N-(2-phenylacetyl)]aminomethyl]-
benzamidopropylamido Tenta gel® 113 using Cyanuric Fluoride 
0 	 0 
H 
H 	?--~ 
'-S  Ph~,,yNyl:)  
0 SEt 
Carboxy-Tentagel® (0.19 g, 0.26 mmol/g), DCM (1 ml) and pyridine (8.0 j.il, 
0.1 mmol) were placed on a blood rotator in an isolute tube (3 ml) for 5 min after 
which cyanuric fluoride (20.7 il, 0.2 mmol) was added and the mixture left on the 
blood rotator for 16 h. The resin was then filtered, washed and dried in vacuo to give 
acyl fluoride functionalised Tentagel®; Um (DCM)/cm 1 1841.6 (COF). To this was 
added 87 (0.08 g, 0.2 mmol), DIEA (17.4 M1. 0.1 mmol) and DMF (1 ml) and the 
mixture left on the blood rotator for 16 h after which the resin was filtered, washed 
UE 
and dried in vacuo to yield the title compound 113 (38 %, 0.09 mmol/g); (Dmax 
(DCM)/cm 1 3513.2 (NH), 2892.9 (CH), 1659.9 (CONH). 
3.7.9 Preparation of 4-[[Ethylsulphanyl-N-(2-phenylacetyl)]aminomethyl)-
benzamidopropylamido Tentagelo 113 using DIC 




H 	H--'-~ 'e 
 Ph,,,yNyl  
0 SEt 
Carboxy-Tentagel® (0.46 g, 0.26 mmol/g), 87 (0.28 g, 0.7 mmol), DIC (0.25 
ml, 1.6 mmol), HOBt (0.21 g, 1.6 mmol) and DMF (3 ml) were placed on a blood 
rotator in an isolute tube (10 in]) for 5 min after which DIEA (0.29 ml, 1.7 mmol) 
was added and the mixture left on the blood rotator for 16 h. The resin was then 
filtered, washed and dried in vacuo to yield the title compound 113 (92 %, 0.22 
mmol/g); Om (DCM)/cm 3507.1 (NH), 2888.9 (CH), 1650.4 (NHCO); i5c (63 
MHz, DCM-D2) 170.3 166.7 (CO), 142.6 135.4 134.2 (Ca), 129.1 128.6 127.4 126.9 
126.6 (CH,), 55.4 (CHSEt), 43.0 (PhCH2), 36.2 (CONHCH2), 36.1 (CH2NHCO), 
29.3 (CH2CH2CH2), 23.4 (SCH2CH3), 14.5 (SCH2CH3). 
3.7.10 Preparation of 4-{[Ethylsulphanyl-N-(2-phenylaceiyl)]aminomethyl)-
benzamidopropylamido Polystyrene 117 using DIC [103] 





Carboxy-polystyrene (0.16 g, 0.98 mmol/g), 87 (0.35 g, 0.9 mmol), DIC (0.32 
ml, 2.0 mmol), HOBt (0.27 g, 2.0 mmol) and DMF (3 ml) were placed on a blood 
rotator in an isolute tube (10 ml) for 5 rnin after which DIEA (0.38 ml, 2.2 nimol) 
was added and the mixture left on the blood rotator for 16 h. The resin was then 
filtered, washed and dried in vacuo to yield the title compound 112 (84 %, 0.60 
mmol/g); Um (DCM)/cm 1 3290.0 (NH), 3053.5 2985.8 (CH), 1673.9 (CONH); 
(63 MHz, DCM-D2) 55.8 (CHSEt), 43.5 (PhCH), 36.4 (CONHCH2), 31.3 
(CH2NHCO), 29.9 (CH2CH2CH2), 25.7 (SCH2CH3), 14.8 (SCH2CH3). 
3.7.11 Preparation of 4- ([Ethylsulphanyl-N-(2-phenylacetyl)]aminomethyl)-
benzamidopropylamido Polystyrene 117 using Cyanuric Fluoride [103] 





Carboxy-polystyrene (0.18 g, 0.98 mmol/g), DCM (1.5 ml) and pyridine (28.5 
p1, 0.4 mmol) were placed on a blood rotator in an isolute tube (5 ml) for 5 min after 
which cyanuric fluoride (75.6 p1, 0.9 mmol) was added and the mixture left on the 
blood rotator for 16 h. The resin was then filtered, washed and dried in vacuo to give 
acyl fluoride functionalised polystyrene 115; Umax (DCM)/cm' 1806.8 (COF). To 
this was added 87 (0.31 g, 0.8 mmol), DIEA (61.5 tl, 0.4 mmol) and DMF (3 ml) 
and the mixture left on the blood rotator for 16 h after which the resin was filtered, 
washed and dried in vacuo to give yield the title compound 117 (92 %, 0.66 mmol/g); 
Umax (DCM)/cm' 3308.1 (NH), 2918.3 (CH), 1651.3 (CONH); 	(63 MHz, DCM- 
132) 55.7 (CHSEt), 43.4 (Phd-I2), 36.2 (CONHCH2), 36.1 (CH2NHCO), 30.8 
(CH2CH2CH2), 25.8 (SCH2CH3), 14.8 (SCH2CH3). 
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3.8. Synthesis of N-Glycopeptide 124 
3.8.1 Coupling of 2-Acetamido-3, 4-di-O-acetyl-2-deoxy-N-(fluoren-9-yl-methoxy 
carbonyl)- 3-D-glucopyranosylamine 106 to 4-([Ethylsulphanyl-N-(2-phenylacetyl)] 
aminomethyl)-benzamidopropylamido Tentagel 0113 








A solution of NIS (0.24 g, 1.07 mmol), dry THF (10 ml) and triflic acid (3 p1, 
31.9 J.imol) was allowed to stand for 30 mm. Meanwhile, 4 A molecular sieves (0.1 
g) were added to a solution of 113 (0.21 g, 0.24 mmol/g) and 106 (0.27 g, 0.50 
mmol) in dry THF (3 ml) and heated to 45 T. An aliquot of NIS solution (1.9 ml) 
was then added and the mixture left at 45 °C for 2 h after which the resin was 
filtered, washed and dried in vacuo to give the desired resin (79 %, 0.17 mmol/g); 
cleavage mixture: mlz (APCI+) 549 (MNa, 38.8 %), 527 (MH, 100.0 %), 136 
(PhCH2CONH3 , 100.0 %). 
3.8.2 Coupling of 2-Acetamido-3, 4-di-O-acetyl-2-deoxy-N-(fluoren-9-yl-methoxy 
carbon yl)-3-D-glucopyranosylamine 106 to 4-1[Ethylsulphanyl-N-(2-phenylacetyl)] 
aminomethyl)-benzamidopropylamido Polystyrene 117 
0 	 0 









A solution of NIS (0.24 g, 1.07 mmol), dry THF (10 ml) and triflic acid (3 p1, 
31.9 tmo1) was allowed to stand for 30 mm. Meanwhile, 4 A molecular sieves (30.0 
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mg) were added to a solution of 117 (15.4 mg, 0.60 mmol/g) and 106 (48.7 mg, 92.4 
tmol) in dry TITF (0.5 ml) and heated to 45 T. An aliquot of NIS solution (0.3 ml) 
was then added and the mixture left at 45 °C for 2 h after which the resin was 
filtered, washed and dried in vacuo to give the desired resin (15 %, 0.07 mmol/g). 
3.8.3 Coupling of N°-(fluoren-9-yl-methoxycarbonyl)-L-aspartic-4acid-1 -Benzyl 
Ester 122a to 4-([2-Acetamido-3,  4-di-O-acetyl-2-deoxy-N-(fluoren-9-yl-
methoxycarbonyl)-3-D-glucopyranosylamine-N-(2-phenylacetyl)]aminomethyl]-
benzamidopropylamido Tentagel 118 










In an isolute tube (10 ml), 118 (0.6 g, 0.11 mmol/g) was treated with 20 % 
piperidine in DMF (5 ml) for 15 min after which the resin was filtered, washed 
successively with DMF (20 ml), THF (15 ml) and DCM (20 ml) and dried under 
suction for 5 min. Fmoc-Asp-OBzl 122a (0.31, 0.7 mmol), HOBt (0.11 g, 0.8 
mmol), TBTU (0.26 g, 0.8 mmol) and DMF (7.5 ml) were then added and the 
mixture placed on a shaker for 5 min after which NMM (55.0 jil, 0.5 mmol) was 
added and the mixture left on the shaker for a further 16 h. The resin was then 
filtered, washed and dried in vacuo to give the desired resin (78 %, 0.09 mmol/g); 
cleavage mixture: m/z (APCI+) 754 (MNa, 24.2 %), 732 (MH, 100.0 %), 624 (Mt-
PhCH20, 33.3 %), 402 (M-PhCH20-Fmoc, 22.4 %), 136 (PhCH2CONH3 , 100.0 
%). 
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3.8.4 Coupling of Fmoc-Amino Acids using TBTU 
In an isolute tube (3 ml), Fmoc-functionalised resin (c.a. 50.0 mg, 1 eq) was 
treated with 20 % piperidine in DMF (1 ml) for 15 min after which the resin was 
filtered, washed successively with DMF (10 ml), THF (10 ml) and DCM (20 ml) and 
dried under suction for 5 mm. Fmoc-AA-OH (10 eq), HOBt (12 eq), TBTU (12 eq) 
and DMF (0.3 ml) were then added and the mixture placed on a blood rotator for 5 
min after which NMM (8 eq) was added and the mixture left on a blood rotator for 
16 h. The resin was then filtered, washed and dried in vacuo to yield Fmoc-amino 
acid functionalised resin (36-100 %). 
3.8.5 Coupling of Fmoc-Amino Acids using Fmoc-Amino Acid Pentafluorophenyl 
Esters and DhbtOH 
In an isolute tube (10 ml), Fmoc-functionalised resin (c.a. 0.50-0.60 g, 0.10-
0.06 mmol/g, 1 eq) was treated with 20 % piperidine in DMF (5 ml) for 15 min after 
which the resin was filtered, washed with DMF (20 ml x 3) and dried under suction 
for 5 mm. A solution of Fmoc-AA-OPfp (10-15 eq), DhbtOH (5 eq) and DMF (4 
ml) was then added and the mixture placed on a shaker for 16 h after which the resin 
was filtered and washed with DMF (20 ml x 2). A second addition of fresh solution 
was added for a further 8 h and the resin was then filtered, washed and dried in vacuo 
to yield Fmoc-amino acid functionalised resin (87-100 %). 
3.8.6 Acetate Capping Procedure 
A solution of acetic anhydride (0.20 ml, 2.1 mmol) in DMF (7m1) was added to 
Fmoc-amino acid functionalised resin (c.a. 0.50-0.60 g) in an isolute tube (10 ml) 
and was placed on a shaker for 8 h after which the resin was then filtered, washed 
and dried in vacuo. 
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3.9. Library Syntheses 
3.9.1 Synthesis of 2-acetamido-3, 4-di-O-acetyl-N-(benzyloxycarbony1)-2-deoxy--D-
glucopyranosylamine on Tentagel' 125  




NyJo 	 0 
ACO NHCb AcO 
NHAc 
In an isolute tube (3 ml), 118 (27.3 mg, 0.14 mmol/g) was treated with 20 % 
piperidine in DMF (2 ml) for 15 min after which the resin was filtered, washed and 
dried in vacuo for 1 h. N-benzyloxycarbonyloxy succinimide (27.4 mg, 0.11 mmol), 
triethylamine (2.1 p1, 15.3 tmol) and DCM (0.6 ml) were then added and placed on a 
blood rotator for 16 h after which the resin was filtered, washed and dried in vacuo to 
give 125 (35 %, 0.05 mmol/g). 
3.9.2 Synthesis of 2-acetamido-N-(benzyloxycarbony1)-2-deoxy-f-D-glucopyranosyl 
amine on Tentage1128 








A mixture of 125 (27.7 mg, 0.05 mmol/g), methanol (0.1 ml), DMF (0.1 ml) 
and triethylamine (19.5 p1, 0.14 mmol) were placed on a blood rotator in an isolute 
tube (3 in]) for 16 h after which the resin was filtered, washed and dried in vacuo to 
yield the desired resin (40 %, 0.02 mmol/g). 
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105 (0.31g, 0.5 mmol) was treated with 20 % piperidine in acetonitrile (3 ml) 
for 5 min after which the solvent was removed in vacuo to give a white solid. This 
crude amino sugar and N-(benzyloxycarbonyloxy) succinimide (0.15 g, 0.6 mmol) 
were then dissolved in anhydrous pyridine (4 ml) and the reaction was stirred at RT 
for 16 h after which TLC (EtOAc) indicated complete transformation of the amino 
starting material. The solvent was azeotroped with toluene in vacuo and the product 
was purified using flash-column chromatography (EtOAc:Hex [1:1]) to yield the title 
compound 127 (0.22 g, 82 %) as a white solid, mp 177-178 °C; Dnax (Nujol)/cm 
3266.7 (NH), 1751.4 (CO), 1710.7 (NHCOO), 1657.6 (NHCO), 1093.4 778.7 (SiO), 
836.0 (Si(CH3)2); 	(250 MHz; CDCI3) 7.29 (5H, s, PhCH2), 6.20 (1H, d, J 9.2, 
NHCbz), 6.16 (1H, d, J 8.5, NHAc), 5.11 (1H, d, J 12.3, PhCH), 5.05 (1H, d, J 12.3, 
PhCH), 5.11-5.05 (2H, m, 3-H 4-H), 4.85 (1H, dd, J 9.2 and 10.1, 1-H), 4.07 (111, 
ddd, J 8.5 10.1 and 10.5, 2-H), 3.73 (1H, dd, J 2.5 and 11.5, 6a-H), 3.64 (111, dd, J 
4.4 and 11.5, 6b-H), 3.55 (1H, m, 5-H), 2.03 (3H, s, OCOCH3), 2.00 (3H, s, 
OCOCH3), 1.87 (3H, s, NHCOCH3), 0.85 (9H, s, C(CH3)3), 0.00 (3H, s, Si(CH3)2); 
(63 MHz) 171.8 171.4 169.1 155.8 (CO), 136.0 (C), 128.3 128.0 127.7 (CH.), 
82.2 (Cl), 75.7 (CS), 73.3 (C3), 68.4 (C4), 66.8 (PhGH2), 62.2 (C6), 53.0 (C2), 25.9 
(C(CH3)3), 22.9 (NHCOCII3), 20.6 (OCOCH3), 18.2 (C(CH3)3), -5.5 (Si(CH3)2); mlz 
(FAB) 553 (MH, 40.7 %), 403 (MH-NHCbz, 1.9 %), 91 (PhCH2 , 100 %), 73 (Ph, 
52.7 %), 43 (Ac, 29.6 %) (Found: MH 553.25786. C26H41N209Si requires 
553.25814). 
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3.9.4 	2-Acetamido-3, 	4-di-O-acetyl- 	N-(benzyloxycarbonyl)-2-deoxy- 13-D- 
glucopyranosylamine 126 
OH 
ACO ?\ NHCb 
NHAc 
To a stirred solution of 127 (0.28 g, 0.5 mmol) in 0.05 % water in DCM (3 ml) 
was added a solution of DDQ (0.02 g, 0.1 mmol) in 0.05 % water in DCM (1 ml) and 
the mixture was stirred at RT for up to 120 h until TLC (EtOAc) indicated that all the 
starting material had been consumed. The solvent was then removed in vacuo to 
yield the crude product and was purified using flash-column chromatography 
(CHC13:MeOH [97:3]) to yield the title compound 126 (0.20 g, 89 %) as a white 
solid, mp 237238 °C, Umax (Nujol)/cm 1 3296.7 (NH OH), 1742.4 (CO), 1701.1 
(NHCOO), 1656.8 (NI-ICO); c (250 MHz; CDC13 CD30D) 7.25 (5H, s, PhCH2), 
5.05 (1H, dd, J 9.5 and 9.8, 3-H), 5.03 (2H, m, PhCH2), 4.92 (1H, dd, J 9.4 and 9.5, 
4-H), 4.79 (1H, d, J 10.0, 1-H), 3.98 (1H, dd, J 9.8 and 10.0, 2-H), 3.62-3.49 (2H, m, 
5-H 6a-H), 3.48 (111, dd, J 4.7 and 12.4, 6b-H), 1.98 (3H, s, OCOCH3), 1.96 (311, s, 
OCOCH3), 1.83 (3H, s, NHCOCH3); i5c (63 MHz) 172.0 171.1 170.0 (CO), 135.6 
(Car), 128.3 128.0 127.7 (CH,,,), 81.5 (Cl), 75.5 (CS), 72.9 (C3), 68.4 (C4), 67.0 
(PhCH2), 60.8 (C6), 52.3 (C2), 22.5 (NHCOCH3), 20.4 (OCOCH3); mlz (FAB) 423 
(MH, 38.7 %), 217 (MHtNHCbz, 21.0 %), 109 (PhCH20, 15.5 %), 91 (PhCH2 , 
100 %) (Found: MH 439.17 145. C20H27N209 requires 439.17166). 
3.9.5 	2-Acetamido-3, 	4, 	6-tri-O-acetyl-N-(benzyloxycarbonyl)-2-deoxy- f3-D 
glucopyranosylamine 130 
OAc 
AcO O\ NHCb 
NHAc 
Under an atmosphere of hydrogen, 102 (1.01 g, 2.7 mmol), platinum (IV) oxide 
(0.10 g, 0.4 mmol) and THF (25 ml) were stirred vigorously at RT for 2 h after 
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which TLC (EtOAc) indicated that all the starting material had been consumed. The 
reaction mixture was concentrated in vacuo to yield yellow oil that contained 
platinum oxide. This crude amino sugar mixture and N-(benzyloxycarbonyloxy) 
succinimide (0.81 g, 3.3 mmol) were then dissolved in anhydrous pyridine (20 ml) 
and the reaction was stirred at RT for 16 h after which TLC (EtOAc) indicated 
complete transformation of the amino starting material. The solvent was azeotroped 
with toluene in vacuo and the product was purified using flash-column 
chromatography (CHCI3:MeOH [98:2]) to yield the title compound 130 (0.85 g, 65 
%) as a white solid, mp 220-221 °C; [c]D  —23.0 (c 1.45, CHC13); Dmax (Nujol)/cm' 
3334.2 (NH), 1747.5 (CO), 1699.1 (NHCOO), 1657.5 (NHCO); 41 (250 MHz; 
CDCI3) 7.29 (5H, s, PhCH2), 6.28 (1H, d, J9.1, NHCbz), 6.18(111, d, J 8.9, NHAc), 
5.13-5.00 (4H, m, 3-H 4-H PhCH2), 4.89 (1H, dd, J 9.1 and 9.3, 1-H), 4.27 (111, dd, J 
4.3 and 12.5, 6b-H), 4.14 (1H, ddd, J 8.9 8.9 and 9.3, 2-H), 4.07 (1H, dd, J 2.2 and 
12.5, 6a-H), 3.71 (1H, m, 5-H), 2.06 (3H, s, OCOCH3), 2.03 (311, s, OCOCH3), 2.01 
(3H, s, OCOCH3), 1.88 (3H, s, NHCOCH3); 	(63 MHz) 171.6 171.4 170.6 169.1 
155.8 (CO), 135.7 (Car), 128.3 128.0 127.8 (GIIar), 82.5 (Cl), 73.1 (C5), 72.9 (C3), 
67.7 (C4), 67.0 (PhCH2), 61.6 (C6), 52.8 (C2), 22.9 (NHCOCH3), 20.6 20.5 20.4 
(OCOCH3); m/z (FAB) 481 (MH, 100 %), 330 (MHtNHCbz, 90.0 %) (Found: 
MH 481.18172. C22F129N2010 requires 481.18222). 
3.9.6 2-Acetamido-N-(benzyloxycarbonyl)-2-deoxy- f3-D-glucopyranosylamine 129 
OH 
HO 0  
HO 	 NHCbz 
NHAc 
To a solution of 130 (0.50 g, 1.0 mmol) in dry methanol (3 ml) was added 
sodium methoxide in methanol (0.5 M, 0.6 ml) and the mixture stirred at RT for 1 h 
after which TLC (EtOAc) indicated complete transformation of the starting material. 
The reaction mixture was filtered through cation ion-exchange resin and the 
methanol evaporated in vacuo to afford the title compound j  (0.35 g, 95 %) as a 
white solid, mp 224-226 °C; [ct]D +10.4 (c 1.09, MeOH); Um (Nujol)/cm' 3271.4 
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(NH OH), 1709.6 (NHCOO), 1651.6 (NHCO); 	(250 MHz; CD30D) 7.42 (51-1, s, 
Phd 2), 5.20 (1H, d, J 12.4, PhCH), 5.15 (1H, d, J 12.4, PhCH), 4.87 (1H, d, J 9.8, 
1-H), 3.93 (1H, dd, J 1.7 and 12.0, 6a-H), 3.81 (1H, dd, J 8.7 and 9.8, 2-H), 3.76 
(1H, dd, J4.9 and 12.0, 6b-H), 3.56 (1H, dd, J 8.7 10.1, 4-H), 3.43-3.39 (21-1, m, 3-H 
5-H), 2.02 (311, s, NHCOCH3); 	(63 MHz) 172.5 156.4 (CO), 136.0 (Caj), 127.6 
127.2 127.0 (CH), 81.1 (Cl), 77.6 (CS), 74.4 (C3), 69.9 (C4), 65.8 (PhCH2), 60.7 
(C6), 54.2 (C2), 20.8 (NHCOCH3); mlz (FAB) 355 (MH, 91.3 %), 217 (MHt 
NHCbz, 48.0 %), 91 (PhCH2 , 100 %) (Found: MH 355.15111. C16H23N207 
requires 355.15053). 
3.9.7 	Coupling 	of 	2-acetamido-N-(benzyloxycarbonyl)-2-deoxy-f3-D- 
glucopyranosylamine 129 to 4-([Ethylsulphanyl-N-(2-phenylaceiyl)] aminomethyl) - 
benzarnidopropylamido Tentagel 113 





Ny-e 	 0 
HOHO NHCb 
NHAc 
A solution of NIS (0.26 g, 1.16 mmol), dry THF (10 ml) and triflic acid (3.2 jil, 
36.2 j.tmol) was allowed to stand for 30 mm. Meanwhile, 4 A molecular sieves (0.1 
g) were added to a solution of 113 (0.20 g, 0.22 mmol/g) and 129 (0.23 g, 0.44 
mmol) in dry THF (3 ml) and heated to 45 T. An aliquot of NIS solution (1.5 ml) 
was then added and the mixture left for 2 h after which the resin was filtered, washed 
and dried in vacuo to give the desired resin (50 %, 0.10 mmol/g). 
3.9.8 General Procedure for Esterfi cation Library [I 10] 
A solution of Carboxylic acid (0.38 mmol), EDCI (72.8 mg, 0.38 mmol) and 
dimethylaminopyridine (46.4 mg, 0.38 mmol) in dry DCM (10 ml) was allowed to 
stand for 10 min after which was added (2 ml) to 128 (c.a. 25.0 mg, 0.10 mmol/g) in 
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an isolute tube (3 ml). The mixture was then left on a blood rotator for 16 h after 
which the resin was filtered, washed and dried in vacuo to yield esterified resin. 
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Appendix 
Al Calculation for the loading of resins using Standard Samples 
For example, calculating the loading for the attachment of Linker 87 onto carboxy-
Tentagel®. 
Two standards run: 1) 20 t1 injection of 0.125 mg/ml gave response 3726503. 
2) 20 tl injection of 0.250 mg/ml gave response 6685999. 
Therefore, Average 20 il injection 1mg/mi gives response 28278010. 
7.5 mg of linker-functionalised Tentagel® 113 was treated with TFA:DCM:H20 
solution. 
HPLC trace from 20 p.1 injection: 




0.000 H. 	j !:f:lf 
Minutes 
6 8.ô0 
Ret. Time = 3.465, Area (uV*  sec) = 6070798. 
Therefore 6070798/28278010 = 0.22 mg/ml 
Theoretically, 100 % coupling from carboxy-Tentagel® (0.26 mmol/g) = 0.237 
mmol/g and so 7.5 mg @ 0.237 mmol/g should give a response of 
(7.5 x 10) x (0.237 x 10) x 135.162 = 0.24 mg/ml. 
Therefore, 
% Yield = (0.22/0.24) x 100 = 92 % 
Loading = 0.212 mmol/g. 
Sugar-functionalised resins 125 and 128 are calculated in the same way. 
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270. 0  30.0 	320.0 	340. 	 37E1. 
WAVELENGTH 
Absorbance at 301 nm = 0.626. 
A2 Calculation of the loading for the attachment of Sugar 106 and amino acids 
using UV analysis 
5.8 mg of resin (0.20 mmol/g) was treated with 20 % piperidine in DMF in a 10 ml 
graduated flask. 
Therefore using equation 1, 
Loading = (0.629 x 10)/(7.8 x 5.8) = 0.14 mmol/g. 
% Yield = (0.14/0.18) x 100 = 78 %. 
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A3 Library LC-MS data 
Figure 18a: LC-MS chrornarograrn data for PhCH 2CO2H. 
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Figure 19b: Mass spectrornetF-v data for MeOC6H4CH2CO2H. 
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a 
Figure 20a: LC-MS chromatogram data for HOC6H4CH2CO2H. 
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Abstract 
A novel linker for the immobilisation of alcohols on solid support is described. This linker can be cleaved either 
enzymatically using penicillin amidase, or by very mild acid hydrolysis using 10% TFA. © 1998 Elsevier Science Ltd. 
All rights reserved. 
Keywords: supported reactions; enzymes; alcohols, carbohydrates. 
The recent surge of interest in solid-phase organic synthesis has resulted in the need for new 
solid-phase methodologies, in particular new linkers for functional groups other than amines 
and carboxylic acids [1]. Enzyme-cleavable linkers are particularly attractive because 
cleavage might be achieved under mild, neutral and aqueous conditions. Two reports have 
demonstrated that enzymes can be used to cleave molecules from solid supports using a 
phosphodiesterase [2] and an endopeptidase (chymotrypsin) [3].  A major drawback of both 
methods is that the compound released from the solid support retains part of the recognition 
site of the enzyme, i.e. a phosphate ester [2] and a peptide with C-terminal phenylalanine 
residues [3].  Although both 'tags' could in principle subsequently be cleaved with 
phosphatases or peptidases respectively, this would introduce several additional synthetic steps 
into the reaction sequences. Here we describe the design and synthesis of a more general 
linker, which can be cleaved either with penicillin amidase (EC 3.5.1.11), a commercially 
available and widely used enzyme [4] or by the use of dilute TFA, thereby complementing the 
existing range of alcohol linkers. 
Penicillin amidase is known to catalyse the hydrolysis of a wide range of amines 
protected as the corresponding phenylacetyl derivatives and has also been used in peptide 
synthesis for the cleavage of cysteine protecting groups [5]. Thus, in order to incorporate the 
enzyme recognition site, the linker 1 was designed as shown in Scheme 1, in which -OR 
'Department of Chemistry, The Edinburgh Centre for Protein Technology, The University of Edinburgh, King's Buildings, West 
Mains Road, Edinburgh EH9 3JJ, UK. 
133 
represents the alcohol group. It was envisaged that cleavage would be initiated by hydrolysis 
of the phenylacetamide moiety, generating the hemiaminal 2 which should easily fragment in 
aqueous medium releasing the alcohol ROH. 






An activated form of the linker was accessible using methodology developed by Katritzky et 
al. [6-8]. The benzotriazole derivative 4 was prepared in 67% yield by refluxing aldehyde 3 
with benzotriazole and phenylacetamide in a Dean-Stark apparatus (Scheme 2). Although the 
benzotriazole is a good leaving group, and can be replaced by strong nucleophiles, we have 
found that the thioethyl group is more convenient for our purposes. The latter can be 
activated with a thiophilic reagent, such as N-iodosuccinimide, and is then susceptible to 
displacement by relatively poor nucleophiles such as secondary alcohols. The thioethyl 
derivative 5 was easily obtained in excellent yield by reaction of 4 with sodium ethanethiolate 
followed by reduction of the azide group to afford the amine 5. 
HYcrA) i 	 ii,Ph 
IcJ 	





(i) Phenylacetamide (1 eq), benzouiazole (1 eq), TsOH (0.2eq), toluene, reflux, Dean-Stark, 16h, 67%; (ii) sodium ethanethiolate (10 
eq.), THF, RT, 4h, 96%; (iii) triphenylphosphine (1.2 eq). 1120, THF, RT, 16h, 96%. 
Amine 5 was then coupled to a variety of solid supports in reasonable to excellent 
yields (Scheme 3)'. A number of Tentagel® and PEGA resins were investigated because of 
their compatibility with aqueous reaction conditions and because they had been reported to be 
suitable for enzyme-catalysed reactions [9].  Coupling yields were between 75% (TentaGel®-
COOH) and 100% (PEGA®-COOH). Polystyrene was also successfully derivatised in 
quantitative yield by activating the resin as the acylfluoride2 and should be useful when the 
'Typical procedure for the coupling of the linker 5 to solid supports (for Tentagel and PEGA resins): A mixture of 
the resin (100 mg; loading 0.2 mmol/g), the linker 5 (50 mg, 0.13 mmol), TBTU (77 mg, 0.24 mmol), HOBt (32 mg, 0.24 mmol) 
and NN-diisopropylethylamine (31 mg, 0.24 mmol) in DMF (2m1) was shaken for 16h at 25 °C. The resin was washed twice with 
10 ml aliquots of THF, DMF, DMF:MeOH (1:1), DMF,THF and CH2Cl2 and dried. 
'Typical procedure for the coupling of the linker 5 to solid supports (for polystyrene resin): Cyanuric fluoride (0.837 
g. 6.2 mmol) was nkkd (with caution) to a suspension of carboxypolystyrene resin (1.00 g; loading 1.24 mmol/g), and pyridine 
(0.200 ml, 2.48 mmol) in dichloromethane (5 ml) and the mixture was agitated on a blood rotator for 16h at 25 °C. The resin was 
washed with 10 ml aliquots of TF{F, DMF. THF and CH2Cl2 and dried in a vacuum oven (v,,,,, 1805 cm-'). N,N. 
Diisopropylethylamine (0.432 ml, 2.48 mmol) was added to a suspension of the linker 5 (2.40 g, 6.23 mmol) and the acyl fluoride 
resin (1.00 g,1.24 mmol/g) in DMF (Sml) and was agitated on a blood rotator for 16h at 25 °C. The resin was washed twice with 10 
ml aliquots of THF, DMF, DMF:MeOH (1:1), DMF,THF and CH202 and dried. 
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(1) 5(6.5 eq), 2-(IH-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium tetrafluoioborate (12 eq), HOBt (12 eq), DIEA (12 eq). DMF, 16h, 
25°C; (ii) 2M NaOH; (iii) 2M HCI; (iv) TFA:DCM:H20 9:10:!; (v) penicillin amidase. 
The loading values of the linker on the resin were determined by hydrolytic cleavage' 
of the phenylacetamide group using either strong acid or base and quantitative determination 
by HPLC of the amount of phenylacetamide or phenylacetic acid released, respectively4. 
These loading values were then used to determine the efficiency of cleavage of the linker 6 
using penicillin amidase'. It was found that penicillin amidase was indeed able to effect 
cleavage of 6, although the yield of enzyme cleavage was strongly dependent on the resin 
used, ranging from 25% for PEGA® to a maximum yield of 50% for TentaGel®. We are 
currently attempting to improve these yields by varying the spacer arm of the linker and also 
by using tailor-made resins that are more compatible with enzyme catalysed reactions [101. 
In view of the susceptibility of the linker to cleavage under mild acid conditions (aqueous 
TFA)6, this protocol was used in subsequent experiments involving attachment of a range of 
alcohols. 
The thioethyl group in 6 was activated by treatment with N-iodosuccinimide followed 
by displacement with a variety of alcohols 7 to 11 (Scheme 4)1•  Fmoc-protected serine 
methylester 7 was found to couple in excellent yield to the polystyrene-linker and could also 
be cleaved quantitatively, as judged by HPLC analysis after acid release. Fmoc analysis of the 
resin bound 7 was in good agreement with the values derived from cleavage reactions. 
Secondary alcohols 8 and 9 gave good yields of coupling. These could possibly be improved 
by double-coupling methods, since analysis of phenylacetamide loading revealed that some of 
the linker had remained intact on the resin. 
'Chemical cleavage of the linker from solid support and determination of the loading: (for Tentagel and PEGA 
resins): A suspension of the resin (2 mg) in 2M HCI (300 psI) or 2M NaOH (300 psI) was shaken for 16h at 25 °C. An aliquot of the 
supernatant solution was neutralised and analysed by HPLC by comparison with standard solutions. 
'HPLC-analysis: HPLC was carried out on a Waters HPLC system with a Phenomenex Sphereclone (Sjsm) ODS2 column (250 
mm x 4.6 mm) using a gradient of two e1unts (25 mM potassium phosphate buffer pH 6.5; acetonilrile). 
'Enzymatic cleavage of the linker from solid support: A solution of penicillin amidase (700 units) in 0.lM potassium 
phosphate buffer (pH 7.5; 0.4 ml) was added to the resin (2 mg) and the mixture was shaken for 16h at 25 °C. The solution was 
removed, treated with 2 M MCI (0.5 ml) and extracted with CH2Cl2 (2 x 5 ml). The combined organic layers we concentrated, the 
remaining residue was dissolved in 300 pd methanol and analysed by HPLC. 
'Cleavage of linker using mild acid conditions (for polystyrene resins): A suspension of the resin (10 mg. 0.01 mmol) in 
CH2Cl2:TFA:H20 (10:9:1 v/v. 4m1) was agitated for 3h. An aliquot (300 jil) was removed, concentrated under reduced pressure, 
dissolved into the same volume of MeOH and analysed by HPLC. 
'Typical procedure for the coupling of alcohols to 6: A suspension of the resin bound linker 6 (50 mg, 0.05 mmol). 
alcohol (7-11) (0.25 mmol) and 4 A molecular sieves in CH2Cl2 (2ml) was agitated on a blood rotator for 30 mm. N-Iodosuccinimide 
(28 mg. 0.13 mmol) (and in the case of alcohols 8, 10 and 11 4jun01 of triflic acid) was aithi and the suspension agitated for a 
further 16h. The resin was washed with twice with 3 ml aliquots of THF, DMF. DMF:MeOH (1:1), DMF, THF. CH2Cl2 and was 
separated from molecular sieves by decantation. 
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Since we were particularly interested in applying the linker to solid phase carbohydrate 
synthesis, the protected glucosides 10 and 11 were coupled to linker 6. Yields of coupling 
were markedly improved to 75% and 80% respectively, by adding catalytic amounts of triflic 
acid (0.125 eq) to the NIS solution. 
Ph 
6 + ROH 
0 OR 
ROH (resin used; combined yields of coupling to 6 and subsequent cleavage): 
)OH 	
—NO2 
° Ph HN CO2Me 	 L) Fmoc 	 0 
7 (Polystyrene; 70%. 
Tentagel; quantitative) 








10 (Tentagel; quantitative) 
	
11 (Polystyrene; 80%) 
Scheme 4 
(i) ROH, N-Iodosuccinimjde, CH2Cl2, RT, 16h. 
In summary, we have developed an efficient synthesis of the linker 6 and have shown 
that a variety of alcohols can be coupled under mild conditions. The linker can be cleaved by 
penicillin amidase, although yields are currently restricted to 50%, or alternatively by 
quantitative mild acid cleavage. Both attachment to, and cleavage from, the linker can be 
achieved under much milder conditions than methodology based on dihydropyran-
functionalised resins [11]. It should therefore be particularly useful for more acid labile 
compounds, such as carbohydrates and acid-labile protecting groups. 
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